BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Vries AC, van Grieken NC, Looman CW, Casparie MK, de Vries E, Meijer GA, Kuipers EJ. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology. 2008;134:945-952. [PMID: 18395075 DOI: 10.1053/j.gastro.2008.01.071] [Cited by in Crossref: 395] [Cited by in F6Publishing: 360] [Article Influence: 28.2] [Reference Citation Analysis]
Number Citing Articles
1 Malfertheiner P. Gastric Atrophy Reversible or Irreversible after <i>Helicobacter pylori</i> Eradication – An Open Question. Digestion 2011;83:250-2. [DOI: 10.1159/000321529] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
2 Zhang Y, Liu Y, Song R, Zhang L, Su Z, Li Y, Chen R, Shi N, Zhao X, Du S, Ding X. Validating traditional Chinese syndrome features in varied stages of chronic gastritis malignant transformation: study protocol for a cross-sectional study. BMJ Open 2018;8:e020939. [PMID: 30166291 DOI: 10.1136/bmjopen-2017-020939] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zagari RM, Marasco G, Tassi V, Ferretti S, Lugaresi M, Fortunato F, Bazzoli F, Mattioli S. Risk of Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus in Patients With Achalasia: A Long-Term Prospective Cohort Study in Italy. Am J Gastroenterol 2021;116:289-95. [DOI: 10.14309/ajg.0000000000000955] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
4 Pérez-mendoza A, Zárate-guzmán Á, Galvis García E, Sobrino Cossío S, Djamus Birch J. Aplicación de la endoscopia sistemática alfanumérica codificada más cromoendoscopia para la detección de lesiones precancerosas gástricas y cáncer gástrico temprano en sujetos con riesgo promedio de cáncer gástrico. Revista de Gastroenterología de México 2018;83:117-24. [DOI: 10.1016/j.rgmx.2017.06.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
5 Tang X, Zhou L, Zhang S, Xu Y, Cui Q, Li L, Lu J, Li P, Lu F, Wang F, Wang P, Bian L, Bian Z. Randomized double-blind clinical trial of Moluodan (摩罗丹) for the treatment of chronic atrophic gastritis with dysplasia. Chin J Integr Med 2016;22:9-18. [DOI: 10.1007/s11655-015-2114-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
6 Wu T, Wu L. The Role and Clinical Implications of the Retinoblastoma (RB)-E2F Pathway in Gastric Cancer. Front Oncol 2021;11:655630. [PMID: 34136392 DOI: 10.3389/fonc.2021.655630] [Reference Citation Analysis]
7 Kuo HY, Chang WL, Yeh YC, Cheng HC, Tsai YC, Wu CT, Lin SH, Yang HB, Lu CC, Sheu BS. Spasmolytic polypeptide-expressing metaplasia associated with higher expressions of miR-21, 155, and 223 can be regressed by Helicobacter pylori eradication in the gastric cancer familial relatives. Helicobacter 2019;24:e12578. [PMID: 30990573 DOI: 10.1111/hel.12578] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
8 So J, Rajnakova A, Chan YH, Tay A, Shah N, Salto-Tellez M, Teh M, Uedo N. Endoscopic tri-modal imaging improves detection of gastric intestinal metaplasia among a high-risk patient population in Singapore. Dig Dis Sci. 2013;58:3566-3575. [PMID: 23996468 DOI: 10.1007/s10620-013-2843-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
9 Waters KM, Salimian KJ, Assarzadegan N, Hutchings D, Makhoul EP, Windon AL, Wong MT, Voltaggio L, Montgomery EA. Cell polarity (the 'four lines') distinguishes gastric dysplasia from epithelial changes in reactive gastropathy. Histopathology 2021;78:453-8. [PMID: 32841414 DOI: 10.1111/his.14242] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Oh JH, Jung SH, Hong SJ, Rhyu MG. DNA Methylation as Surrogate Marker For Gastric Cancer. J Cancer Prev 2015;20:172-8. [PMID: 26473155 DOI: 10.15430/JCP.2015.20.3.172] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
11 Kuipers EJ. Pernicious Anemia, Atrophic Gastritis, and the Risk of Cancer. Clin Gastroenterol Hepatol 2015;13:2290-2. [PMID: 26192144 DOI: 10.1016/j.cgh.2015.07.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
12 Chung SJ, Park MJ, Kang SJ, Kang HY, Chung GE, Kim SG, Jung HC. Effect of annual endoscopic screening on clinicopathologic characteristics and treatment modality of gastric cancer in a high-incidence region of Korea. Int J Cancer. 2012;131:2376-2384. [PMID: 22362223 DOI: 10.1002/ijc.27501] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 4.8] [Reference Citation Analysis]
13 Yoon K, Kim N. Reversibility of Atrophic Gastritis and Intestinal Metaplasia by Eradication of Helicobacter pylori. Korean J Gastroenterol 2018;72:104. [DOI: 10.4166/kjg.2018.72.3.104] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Hatta W, Gotoda T, Koike T, Masamune A. Management following endoscopic resection in elderly patients with early-stage upper gastrointestinal neoplasia. Dig Endosc 2020;32:861-73. [PMID: 31802529 DOI: 10.1111/den.13592] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
15 Leja M, Wex T, Malfertheiner P. Markers for gastric cancer premalignant lesions: where do we go? Dig Dis. 2012;30:268-276. [PMID: 22722551 DOI: 10.1159/000336990] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
16 Lin JT. Screening of gastric cancer: who, when, and how. Clin Gastroenterol Hepatol. 2014;12:135-138. [PMID: 24107396 DOI: 10.1016/j.cgh.2013.09.064] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
17 Huang KK, Ramnarayanan K, Zhu F, Srivastava S, Xu C, Tan ALK, Lee M, Tay S, Das K, Xing M, Fatehullah A, Alkaff SMF, Lim TKH, Lee J, Ho KY, Rozen SG, Teh BT, Barker N, Chia CK, Khor C, Ooi CJ, Fock KM, So J, Lim WC, Ling KL, Ang TL, Wong A, Rao J, Rajnakova A, Lim LG, Yap WM, Teh M, Yeoh KG, Tan P. Genomic and Epigenomic Profiling of High-Risk Intestinal Metaplasia Reveals Molecular Determinants of Progression to Gastric Cancer. Cancer Cell 2018; 33: 137-150. e5. [PMID: 29290541 DOI: 10.1016/j.ccell.2017.11.018] [Cited by in Crossref: 84] [Cited by in F6Publishing: 90] [Article Influence: 16.8] [Reference Citation Analysis]
18 O’Connor A, McNamara D, O’Moráin CA. Surveillance of gastric intestinal metaplasia for the prevention of gastric cancer. Cochrane Database Syst Rev. 2013;9:CD009322. [PMID: 24062262 DOI: 10.1002/14651858.cd009322.pub2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
19 Xu X, Feng L, Liu Y, Zhou WX, Ma YC, Fei GJ, An N, Li Y, Wu X, Yao F, Cheng SJ, Lu XH. Differential gene expression profiling of gastric intraepithelial neoplasia and early-stage adenocarcinoma. World J Gastroenterol 2014; 20(47): 17883-17893 [PMID: 25548486 DOI: 10.3748/wjg.v20.i47.17883] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
20 Moon HS, Yun GY, Kim JS, Eun HS, Kang SH, Sung JK, Jeong HY, Song KS. Risk factors for metachronous gastric carcinoma development after endoscopic resection of gastric dysplasia: Retrospective, single-center study. World J Gastroenterol 2017; 23(24): 4407-4415 [PMID: 28706423 DOI: 10.3748/wjg.v23.i24.4407] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
21 Sun Y, Wang S, Qi M, Wu M, Zhang D, Yang Y, Zhao X, Jia J, Cao F, Su Y, Zhang S. Psychological distress in patients with chronic atrophic gastritis: the risk factors, protection factors, and cumulative effect. Psychology, Health & Medicine 2018;23:797-803. [DOI: 10.1080/13548506.2018.1428756] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Rugge M, Fassan M, Pizzi M, Farinati F, Sturniolo GC, Plebani M, Graham DY. Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment. World J Gastroenterol 2011; 17(41): 4596-4601 [PMID: 22147965 DOI: 10.3748/wjg.v17.i41.4596] [Cited by in CrossRef: 69] [Cited by in F6Publishing: 62] [Article Influence: 6.3] [Reference Citation Analysis]
23 Quiroz-Guadarrama CD, Herrera-Esquivel JJ, Rojano-Rodríguez M, Del Rio-Suarez I, Morales-Vargas JM, Mucio M. Endoscopic gastric submucosal dissection in low-grade intraepithelial neoplasia. Rev Gastroenterol Mex 2014;79:149-51. [PMID: 24880529 DOI: 10.1016/j.rgmx.2013.10.002] [Reference Citation Analysis]
24 Hwang JJ, Lee DH, Yoon H, Shin CM, Park YS, Kim N. Clinicopathological characteristics of patients who underwent additional gastrectomy after incomplete endoscopic resection for early gastric cancer. Medicine (Baltimore). 2017;96:e6172. [PMID: 28207556 DOI: 10.1097/md.0000000000006172] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
25 Yakirevich E, Resnick MB. Pathology of gastric cancer and its precursor lesions. Gastroenterol Clin North Am. 2013;42:261-284. [PMID: 23639640 DOI: 10.1016/j.gtc.2013.01.004] [Cited by in Crossref: 77] [Cited by in F6Publishing: 67] [Article Influence: 8.6] [Reference Citation Analysis]
26 Kim JW, Jang JY. Optimal management of biopsy-proven low-grade gastric dysplasia. World J Gastrointest Endosc 2015; 7(4): 396-402 [PMID: 25901219 DOI: 10.4253/wjge.v7.i4.396] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
27 Tong Y, Wang H, Zhao Y, He X, Xu H, Li H, Shuai P, Gong L, Wu H, Xu H, Luo Y, Wang D, Liu S, Song Z. Serum pepsinogen levels in different regions of China and its influencing factors: a multicenter cross-sectional study. BMC Gastroenterol 2021;21:264. [PMID: 34118868 DOI: 10.1186/s12876-021-01794-6] [Reference Citation Analysis]
28 Hong JB, Zuo W, Wang AJ, Xu S, Tu LX, Chen YX, Zhu X, Lu NH. Gastric ulcer patients are more susceptible to developing gastric cancer compared with concomitant gastric and duodenal ulcer patients. Oncol Lett 2014;8:2790-4. [PMID: 25364467 DOI: 10.3892/ol.2014.2583] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
29 Nam JH, Choi IJ, Kook MC, Lee JY, Cho SJ, Nam SY, Kim CG. OLGA and OLGIM stage distribution according to age and Helicobacter pylori status in the Korean population. Helicobacter. 2014;19:81-89. [PMID: 24617667 DOI: 10.1111/hel.12112] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
30 Sugano K, Tack J, Kuipers EJ, Graham DY, El-Omar EM, Miura S, Haruma K, Asaka M, Uemura N, Malfertheiner P;  faculty members of Kyoto Global Consensus Conference. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64:1353-1367. [PMID: 26187502 DOI: 10.1136/gutjnl-2015-309252] [Cited by in Crossref: 609] [Cited by in F6Publishing: 507] [Article Influence: 87.0] [Reference Citation Analysis]
31 Loong TH, Soon NC, Nik Mahmud NRK, Naidu J, Rani RA, Abdul Hamid N, Elias MH, Mohamed Rose I, Tamil A, Mokhtar NM, Raja Ali RA. Serum pepsinogen and gastrin-17 as potential biomarkers for pre-malignant lesions in the gastric corpus. Biomed Rep 2017;7:460-8. [PMID: 29181158 DOI: 10.3892/br.2017.985] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
32 Li D, Bautista MC, Jiang SF, Daryani P, Brackett M, Armstrong MA, Hung YY, Postlethwaite D, Ladabaum U. Risks and Predictors of Gastric Adenocarcinoma in Patients with Gastric Intestinal Metaplasia and Dysplasia: A Population-Based Study. Am J Gastroenterol. 2016;111:1104-1113. [PMID: 27185078 DOI: 10.1038/ajg.2016.188] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 9.5] [Reference Citation Analysis]
33 Doulberis M, Pierre NT, Manzini G, Papaefthymiou A, Kountouras J, Klukowska-Rötzler J, Polyzos SA, Srivastava S, Exadaktylos AK, Knuchel J, Kuntzen T, Srivastava DS. Helicobacter pylori-Related Metabolic Parameters and Premalignant Gastric Mucosa Histological Lesions in Swiss Bariatric Patients. Microorganisms 2021;9:1361. [PMID: 34201748 DOI: 10.3390/microorganisms9071361] [Reference Citation Analysis]
34 Hong JB, Zuo W, Wang AJ, Xu S, Zhu HT, Zhu Y, Lv NH. Clinical and endoscopic features of gastrointestinal ulcer with fungal infection: Analysis of 240 cases. Shijie Huaren Xiaohua Zazhi 2015; 23(20): 3283-3288 [DOI: 10.11569/wcjd.v23.i20.3283] [Reference Citation Analysis]
35 Liu JD. Clinical features of low-grade gastric intraepithelial neoplasia. Shijie Huaren Xiaohua Zazhi 2014; 22(20): 2914-2917 [DOI: 10.11569/wcjd.v22.i20.2914] [Reference Citation Analysis]
36 Zeng J, Ma X, Zhao Z, Chen Y, Wang J, Hao Y, Yu J, Zeng Z, Chen N, Zhao M, Tang J, Gong D. Ginsenoside Rb1 Lessens Gastric Precancerous Lesions by Interfering With β-Catenin/TCF4 Interaction. Front Pharmacol 2021;12:682713. [PMID: 34594214 DOI: 10.3389/fphar.2021.682713] [Reference Citation Analysis]
37 Ji R, Zhang Z, Zhang J, Wu Z, Li M, Ye Y, Li X, An F, Xu C, Lu L, Fan P, Chen Z, Guo Q, Wang Y, Wang X, Li Y, Zhang J, Guan Q, Hu X, Yang T, Liu J, Qiao L, Zheng Y, Zhou Y. Cohort Profile: A population-based cohort for the study of gastric cancer in northwest area of China (Wuwei Cohort). Int J Epidemiol 2021:dyab083. [PMID: 34143880 DOI: 10.1093/ije/dyab083] [Reference Citation Analysis]
38 Togo K, Ueo T, Yao K, Wada K, Honda H, Inoue S, Fukuda M, Yanai Y, Yonemasu H, Murakami K. White opaque substance visualized by magnifying narrow-band imaging is associated with intragastric acid conditions. Endosc Int Open. 2018;6:E830-E837. [PMID: 29978002 DOI: 10.1055/a-0611-4825] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
39 Lau JWL, Khoo MJW, Leong XH, Lim TZ, Shabbir A, Yeoh KG, Koh CJ, So JBY. Opportunistic upper endoscopy during colonoscopy as a screening strategy for countries with intermediate gastric cancer risk. J Gastroenterol Hepatol 2021;36:1081-7. [PMID: 33037826 DOI: 10.1111/jgh.15290] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Lee T, Wang R, Lee Y, Lin J, Ho HJ, Hsieh M, Wu C. The Incidence of Gastric Adenocarcinoma Among Patients With Gastric Intestinal Metaplasia: A Long-term Cohort Study. Journal of Clinical Gastroenterology 2016;50:532-7. [DOI: 10.1097/mcg.0000000000000406] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 3.2] [Reference Citation Analysis]
41 Kuang M, Cheng J, Zhang C, Feng L, Xu X, Zhang Y, Zu M, Cui J, Yu H, Zhang K, Yang A, Cheng S. A novel signature for stratifying the molecular heterogeneity of the tissue-infiltrating T-cell receptor repertoire reflects gastric cancer prognosis. Sci Rep 2017;7:7762. [PMID: 28798410 DOI: 10.1038/s41598-017-08289-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
42 Zhang HY, Huang XY, Xue HG, Yang AH, Sun XG, Liu XS. Risk factors for development of gastric cancer in chronic atrophic gastritis: A long-term follow-up study. Shijie Huaren Xiaohua Zazhi 2018; 26(31): 1812-1817 [DOI: 10.11569/wcjd.v26.i31.1812] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Gurusamy KS, Pallari E. Medical versus surgical treatment for refractory or recurrent peptic ulcer. Cochrane Database Syst Rev. 2016;3:CD011523. [PMID: 27025289 DOI: 10.1002/14651858.cd011523.pub2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
44 Liu W, Zhao ZM, Liu YL, Pan HF, Lin LZ. Weipiling ameliorates gastric precancerous lesions in Atp4a-/- mice. BMC Complement Altern Med 2019;19:318. [PMID: 31744486 DOI: 10.1186/s12906-019-2718-y] [Reference Citation Analysis]
45 Lin R, Li C, Liu Z, Wu R, Lu J. Genome-wide DNA methylation profiling identifies epigenetic signatures of gastric cardiac intestinal metaplasia. J Transl Med 2020;18:292. [PMID: 32736574 DOI: 10.1186/s12967-020-02453-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
46 Waddingham W, Nieuwenburg SAV, Carlson S, Rodriguez-Justo M, Spaander M, Kuipers EJ, Jansen M, Graham DG, Banks M. Recent advances in the detection and management of early gastric cancer and its precursors. Frontline Gastroenterol 2021;12:322-31. [PMID: 34249318 DOI: 10.1136/flgastro-2018-101089] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
47 Oz Puyan F, Can N, Ozyilmaz F, Usta U, Sut N, Tastekin E, Altaner S. The relationship among PDX1, CDX2, and mucin profiles in gastric carcinomas; correlations with clinicopathologic parameters. J Cancer Res Clin Oncol. 2011;137:1749-1762. [PMID: 21909647 DOI: 10.1007/s00432-011-1044-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
48 Rugge M, Capelle LG, Cappellesso R, Nitti D, Kuipers EJ. Precancerous lesions in the stomach: from biology to clinical patient management. Best Pract Res Clin Gastroenterol. 2013;27:205-223. [PMID: 23809241 DOI: 10.1016/j.bpg.2012.12.007] [Cited by in Crossref: 66] [Cited by in F6Publishing: 59] [Article Influence: 7.3] [Reference Citation Analysis]
49 Hwang JJ, Lee DH, Lee AR, Yoon H, Shin CM, Park YS, Kim N. Characteristics of gastric cancer in peptic ulcer patients with Helicobacter pylori infection. World J Gastroenterol 2015; 21(16): 4954-4960 [PMID: 25945009 DOI: 10.3748/wjg.v21.i16.4954] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
50 Hong JB, Zuo W, Wang AJ, Lu NH. Helicobacter pylori Infection Synergistic with IL-1β Gene Polymorphisms Potentially Contributes to the Carcinogenesis of Gastric Cancer. Int J Med Sci. 2016;13:298-303. [PMID: 27076787 DOI: 10.7150/ijms.14239] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
51 Leja M, You W, Camargo MC, Saito H. Implementation of gastric cancer screening - the global experience. Best Pract Res Clin Gastroenterol. 2014;28:1093-1106. [PMID: 25439074 DOI: 10.1016/j.bpg.2014.09.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
52 Pittayanon R, Rerknimitr R, Klaikaew N, Sanpavat A, Chaithongrat S, Mahachai V, Kullavanijaya P, Barkun A. The risk of gastric cancer in patients with gastric intestinal metaplasia in 5-year follow-up. Aliment Pharmacol Ther. 2017;46:40-45. [PMID: 28449219 DOI: 10.1111/apt.14082] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
53 Muto M, Yao K, Kaise M, Kato M, Uedo N, Yagi K, Tajiri H. Magnifying endoscopy simple diagnostic algorithm for early gastric cancer (MESDA-G). Dig Endosc. 2016;28:379-393. [PMID: 26896760 DOI: 10.1111/den.12638] [Cited by in Crossref: 93] [Cited by in F6Publishing: 77] [Article Influence: 15.5] [Reference Citation Analysis]
54 Huang HL, Leung CY, Saito E, Katanoda K, Hur C, Kong CY, Nomura S, Shibuya K. Effect and cost-effectiveness of national gastric cancer screening in Japan: a microsimulation modeling study. BMC Med 2020;18:257. [PMID: 32921305 DOI: 10.1186/s12916-020-01729-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
55 Liu W, Pan HF, Wang Q, Zhao ZM. The application of transgenic and gene knockout mice in the study of gastric precancerous lesions. Pathol Res Pract 2018;214:1929-39. [PMID: 30477641 DOI: 10.1016/j.prp.2018.10.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
56 Kim HJ, Choi BY, Byun TJ, Eun CS, Song KS, Kim YS, Han DS. The Prevalence of Atrophic Gastritis and Intestinal Metaplasia according to Gender, Age and Helicobacter Pylori Infection in a Rural Population. J Prev Med Public Health 2008;41:373. [DOI: 10.3961/jpmph.2008.41.6.373] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
57 Holme Ø, Løberg M. Methodological considerations for surveillance in GI practice. Best Pract Res Clin Gastroenterol 2016;30:867-78. [PMID: 27938782 DOI: 10.1016/j.bpg.2016.10.011] [Reference Citation Analysis]
58 Abdelfattah T, Shahab O, Shah TU. Gastric intestinal metaplasia: when to treat? How to treat? Curr Opin Gastroenterol 2021;37:602-8. [PMID: 34432654 DOI: 10.1097/MOG.0000000000000784] [Reference Citation Analysis]
59 Jiang JX, Liu Q, Zhao B, Zhang HH, Sang HM, Djaleel SM, Zhang GX, Xu SF. Risk factors for intestinal metaplasia in a southeastern Chinese population: an analysis of 28,745 cases. J Cancer Res Clin Oncol 2017;143:409-18. [PMID: 27832356 DOI: 10.1007/s00432-016-2299-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
60 Savarino E, Corbo M, Dulbecco P, Gemignani L, Giambruno E, Mastracci L, Grillo F, Savarino V. Narrow-band imaging with magnifying endoscopy is accurate for detecting gastric intestinal metaplasia. World J Gastroenterol 2013; 19(17): 2668-2675 [PMID: 23674874 DOI: 10.3748/wjg.v19.i17.2668] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
61 Dilaghi E, Baldaro F, Pilozzi E, Conti L, Palumbo A, Esposito G, Annibale B, Lahner E. Pseudopyloric Metaplasia Is Not Associated With the Development of Gastric Cancer. Am J Gastroenterol 2021;116:1859-67. [PMID: 34313623 DOI: 10.14309/ajg.0000000000001390] [Reference Citation Analysis]
62 Bang CS, Lee JJ, Baik GH. Prediction of Chronic Atrophic Gastritis and Gastric Neoplasms by Serum Pepsinogen Assay: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy. J Clin Med 2019;8:E657. [PMID: 31083485 DOI: 10.3390/jcm8050657] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
63 Capelle LG, de Vries AC, Looman CW, Casparie MK, Boot H, Meijer GA, Kuipers EJ. Gastric MALT lymphoma: epidemiology and high adenocarcinoma risk in a nation-wide study. Eur J Cancer. 2008;44:2470-2476. [PMID: 18707866 DOI: 10.1016/j.ejca.2008.07.005] [Cited by in Crossref: 70] [Cited by in F6Publishing: 53] [Article Influence: 5.0] [Reference Citation Analysis]
64 Dinis-ribeiro M, Areia M, de Vries AC, Marcos-pinto R, Monteiro-soares M, O’connor A, Pereira C, Pimentel-nunes P, Correia R, Ensari A, Dumonceau JM, Machado JC, Macedo G, Malfertheiner P, Matysiak-budnik T, Megraud F, Miki K, O’morain C, Peek RM, Ponchon T, Ristimaki A, Rembacken B, Carneiro F, Kuipers EJ; on behalf of MAPS Participants. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Virchows Arch 2012;460:19-46. [DOI: 10.1007/s00428-011-1177-8] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 4.9] [Reference Citation Analysis]
65 den Hoed CM, van Eijck BC, Capelle LG, van Dekken H, Biermann K, Siersema PD, Kuipers EJ. The prevalence of premalignant gastric lesions in asymptomatic patients: predicting the future incidence of gastric cancer. Eur J Cancer. 2011;47:1211-1218. [PMID: 21239166 DOI: 10.1016/j.ejca.2010.12.012] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
66 Sagatun L, Fossmark R, Jianu CS, Qvigstad G, Nordrum IS, Mjønes P, Waldum HL. Follow-up of patients with ECL cell-derived tumours. Scand J Gastroenterol 2016;51:1398-405. [PMID: 27309188 DOI: 10.3109/00365521.2016.1169588] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
67 Sekikawa A, Fukui H, Maruo T, Tsumura T, Okabe Y, Osaki Y. Diabetes mellitus increases the risk of early gastric cancer development. Eur J Cancer. 2014;50:2065-2071. [PMID: 24934410 DOI: 10.1016/j.ejca.2014.05.020] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
68 Xie Y, Liu L. Analysis of correlation between HP infection and activation of PI3K/Akt pathway in mucosal tissues of gastric cancer and precancerous lesions. Oncol Lett 2018;16:5615-20. [PMID: 30344716 DOI: 10.3892/ol.2018.9329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
69 Serrano M, Kikuste I, Dinis-Ribeiro M. Advanced endoscopic imaging for gastric cancer assessment: new insights with new optics? Best Pract Res Clin Gastroenterol. 2014;28:1079-1091. [PMID: 25439073 DOI: 10.1016/j.bpg.2014.10.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
70 Yang L, Li J, Hu Z, Fan X, Cai T, Hengli Zhou, Pan H. A Systematic Review of the Mechanisms Underlying Treatment of Gastric Precancerous Lesions by Traditional Chinese Medicine. Evid Based Complement Alternat Med 2020;2020:9154738. [PMID: 32454874 DOI: 10.1155/2020/9154738] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
71 Nieminen A, Kontto J, Puolakkainen P, Virtamo J, Kokkola A. Long-term gastric cancer risk in male smokers with atrophic corpus gastritis. Scand J Gastroenterol. 2019;54:145-151. [PMID: 30700174 DOI: 10.1080/00365521.2019.1566492] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
72 Quach DT, Le HM, Nguyen OT, Nguyen TS, Uemura N. The severity of endoscopic gastric atrophy could help to predict Operative Link on Gastritis Assessment gastritis stage. J Gastroenterol Hepatol. 2011;26:281-285. [PMID: 21261717 DOI: 10.1111/j.1440-1746.2010.06474.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
73 Waddingham W, Graham D, Banks M, Jansen M. The evolving role of endoscopy in the diagnosis of premalignant gastric lesions. F1000Res. 2018;7. [PMID: 29946429 DOI: 10.12688/f1000research.12087.1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
74 Cunha LL, Ferreira RC, Marcello MA, Vassallo J, Ward LS. Clinical and pathological implications of concurrent autoimmune thyroid disorders and papillary thyroid cancer. J Thyroid Res 2011;2011:387062. [PMID: 21403889 DOI: 10.4061/2011/387062] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
75 Dhingra R, Natov NS, Daaboul Y, Guelrud M, Cherukara A, Hung PF, Sterling MJ. Increased Risk of Progression to Gastric Adenocarcinoma in Patients with Non-dysplastic Gastric Intestinal Metaplasia Versus a Control Population. Dig Dis Sci 2020;65:3316-23. [PMID: 31916085 DOI: 10.1007/s10620-019-06031-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
76 Aumpan N, Vilaichone RK, Nunanan P, Chonprasertsuk S, Siramolpiwat S, Bhanthumkomol P, Pornthisarn B, Uchida T, Vilaichone V, Wongcha-Um A, Yamaoka Y, Mahachai V. Predictors for development of complete and incomplete intestinal metaplasia (IM) associated with H. pylori infection: A large-scale study from low prevalence area of gastric cancer (IM-HP trial). PLoS One 2020;15:e0239434. [PMID: 33002050 DOI: 10.1371/journal.pone.0239434] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
77 Icaza-Chávez ME, Tanimoto MA, Huerta-Iga FM, Remes-Troche JM, Carmona-Sánchez R, Ángeles-Ángeles A, Bosques-Padilla FJ, Blancas-Valencia JM, Grajales-Figueroa G, Hernández-Mondragón OV, Hernández-Guerrero AI, Herrera-Servín MA, Huitzil-Meléndez FD, Kimura-Fujikami K, León-Rodríguez E, Medina-Franco H, Ramírez-Luna MA, Sampieri CL, Vega-Ramos B, Zentella-Dehesa A. The Mexican consensus on the detection and treatment of early gastric cancer. Rev Gastroenterol Mex (Engl Ed) 2020;85:69-85. [PMID: 31859080 DOI: 10.1016/j.rgmx.2019.10.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
78 Zou TH, Zheng RH, Gao QY, Kong X, Chen XY, Ge ZZ, Chen YX, Zou XP, Fang JY. Factors affecting occurrence of gastric varioliform lesions: A case-control study. World J Gastroenterol 2016; 22(22): 5228-5236 [PMID: 27298565 DOI: 10.3748/wjg.v22.i22.5228] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
79 Chang LL, Zhang KG. Progress in research of gastric intraepithelial neoplasia. Shijie Huaren Xiaohua Zazhi 2015; 23(9): 1426-1432 [DOI: 10.11569/wcjd.v23.i9.1426] [Reference Citation Analysis]
80 Varbanova M, Wex T, Jechorek D, Röhl F, Langner C, Selgrad M, Malfertheiner P. Impact of the angulus biopsy for the detection of gastric preneoplastic conditions and gastric cancer risk assessment. J Clin Pathol 2015;69:19-25. [DOI: 10.1136/jclinpath-2015-202858] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
81 Zhang P, Yang M, Zhang Y, Xiao S, Lai X, Tan A, Du S, Li S. Dissecting the Single-Cell Transcriptome Network Underlying Gastric Premalignant Lesions and Early Gastric Cancer. Cell Reports 2019;27:1934-1947.e5. [DOI: 10.1016/j.celrep.2019.04.052] [Cited by in Crossref: 70] [Cited by in F6Publishing: 57] [Article Influence: 23.3] [Reference Citation Analysis]
82 Du Y, Bai Y, Xie P, Fang J, Wang X, Hou X, Tian D, Wang C, Liu Y, Sha W, Wang B, Li Y, Zhang G, Shi R, Xu J, Huang M, Han S, Liu J, Ren X, Wang Z, Cui L, Sheng J, Luo H, Zhao X, Dai N, Nie Y, Zou Y, Xia B, Fan Z, Chen Z, Lin S, Li ZS;  Chinese Chronic Gastritis Research group. Chronic gastritis in China: a national multi-center survey. BMC Gastroenterol. 2014;14:21. [PMID: 24502423 DOI: 10.1186/1471-230x-14-21] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
83 de Vries AC, Capelle LG, Looman CW, van Blankenstein M, van Grieken NC, Casparie MK, Meijer GA, Kuipers EJ. Increased risk of esophageal squamous cell carcinoma in patients with gastric atrophy: independent of the severity of atrophic changes. Int J Cancer. 2009;124:2135-2138. [PMID: 19107937 DOI: 10.1002/ijc.23955] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
84 Sheu BS, Wu MS, Chiu CT, Lo JC, Wu DC, Liou JM, Wu CY, Cheng HC, Lee YC, Hsu PI, Chang CC, Chang WL, Lin JT. Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale. Helicobacter. 2017;22. [PMID: 28066960 DOI: 10.1111/hel.12368] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 8.0] [Reference Citation Analysis]
85 Peek RM. Prevention of Gastric Cancer: When is Treatment of Helicobacter Pylori Warranted? Therap Adv Gastroenterol 2008;1:19-31. [PMID: 20953278 DOI: 10.1177/1756283X08093567] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
86 Tang ZY, Ye ZM, Zheng JH, Jiang F, Tang YM. A comprehensive evaluation of single nucleotide polymorphisms associated with atrophic gastritis risk: A protocol for systematic review and network meta-analysis. Medicine (Baltimore) 2020;99:e20677. [PMID: 32702817 DOI: 10.1097/MD.0000000000020677] [Reference Citation Analysis]
87 Saberi S, Esmaeili M, Tashakoripour M, Eshagh Hosseini M, Baharvand H, Mohammadi M. Infection with a hypervirulent strain of Helicobacter pylori primes gastric cells toward intestinal transdifferentiation. Microb Pathog 2021;162:105353. [PMID: 34896202 DOI: 10.1016/j.micpath.2021.105353] [Reference Citation Analysis]
88 Kim YI, Park JY, Kim BJ, Hwang HW, Hong SA, Kim JG. Risk of metachronous gastric neoplasm occurrence during intermediate-term follow-up period after endoscopic submucosal dissection for gastric dysplasia. Sci Rep. 2020;10:6747. [PMID: 32317745 DOI: 10.1038/s41598-020-63722-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
89 Jung JT. Gastric polyps and protruding type gastric cancer. Clin Endosc 2013;46:243-7. [PMID: 23767034 DOI: 10.5946/ce.2013.46.3.243] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
90 Quach DT, Le HM, Hiyama T, Nguyen OT, Nguyen TS, Uemura N. Relationship between endoscopic and histologic gastric atrophy and intestinal metaplasia. Helicobacter. 2013;18:151-157. [PMID: 23167960 DOI: 10.1111/hel.12027] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
91 Zullo A, Hassan C, Repici A, Annibale B. Intestinal metaplasia surveillance: Searching for the road-map. World J Gastroenterol 2013; 19(10): 1523-1526 [PMID: 23539645 DOI: 10.3748/wjg.v19.i10.1523] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
92 Marqués-Lespier JM, González-Pons M, Cruz-Correa M. Current Perspectives on Gastric Cancer. Gastroenterol Clin North Am 2016;45:413-28. [PMID: 27546840 DOI: 10.1016/j.gtc.2016.04.002] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 11.8] [Reference Citation Analysis]
93 Bloomquist MS, Powell J 3rd, Masand RP, Dhall D, Karamchandani DM, Jain S. Lack of uniformity in reporting autoimmune gastritis among a diverse group of pathologists. Ann Diagn Pathol 2021;56:151840. [PMID: 34773775 DOI: 10.1016/j.anndiagpath.2021.151840] [Reference Citation Analysis]
94 Kinoshita H, Hayakawa Y, Konishi M, Hata M, Tsuboi M, Hayata Y, Hikiba Y, Ihara S, Nakagawa H, Ikenoue T, Ushiku T, Fukayama M, Hirata Y, Koike K. Three types of metaplasia model through Kras activation, Pten deletion, or Cdh1 deletion in the gastric epithelium. J Pathol. 2019;247:35-47. [PMID: 30168144 DOI: 10.1002/path.5163] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
95 Svrcek M. [High-grade gastric intra-epithelial neoplasia (or dysplasia) treated by endoscopic mucosal resection]. Ann Pathol 2011;31:375-80. [PMID: 21982245 DOI: 10.1016/j.annpat.2011.07.006] [Reference Citation Analysis]
96 Sturgeon CM, Duffy MJ, Hofmann BR, Lamerz R, Fritsche HA, Gaarenstroom K, Bonfrer J, Ecke TH, Grossman HB, Hayes P, Hoffmann RT, Lerner SP, Löhe F, Louhimo J, Sawczuk I, Taketa K, Diamandis EP; National Academy of Clinical Biochemistry. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers. Clin Chem 2010;56:e1-48. [PMID: 20207771 DOI: 10.1373/clinchem.2009.133124] [Cited by in Crossref: 146] [Cited by in F6Publishing: 119] [Article Influence: 12.2] [Reference Citation Analysis]
97 Cheung DY. Atrophic Gastritis Increases the Risk of Gastric Cancer in Asymptomatic Population in Korea. Gut Liver 2017;11:575-6. [PMID: 28874038 DOI: 10.5009/gnl17356] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
98 Wang N, Chen M, Ni Z, Li T, Zeng J, Lu G, Wang J, Zhang J, Wu S, Shi Y. HDAC6/HNF4α loop mediated by miR-1 promotes bile acids-induced gastric intestinal metaplasia. Gastric Cancer 2021;24:103-16. [PMID: 32705446 DOI: 10.1007/s10120-020-01108-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
99 Zhang M, Liu S, Hu Y, Bao HB, Meng LN, Wang XT, Xu Y, Zhao J, Lu B. Biopsy strategies for endoscopic screening of pre-malignant gastric lesions. Sci Rep 2019;9:14909. [PMID: 31624309 DOI: 10.1038/s41598-019-51487-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
100 Li S, Chung DC, Mullen JT. Screening high-risk populations for esophageal and gastric cancer. J Surg Oncol. 2019;120:831-846. [PMID: 31373005 DOI: 10.1002/jso.25656] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
101 Fang JH, Zhou G, Yu W, Chen X, Sun YT, Li GX. Clinicopathological characteristics of gastric intraepithelial neoplasia: Analysis of 653 cases. Shijie Huaren Xiaohua Zazhi 2021; 29(18): 1064-1070 [DOI: 10.11569/wcjd.v29.i18.1064] [Reference Citation Analysis]
102 Mera RM, Bravo LE, Camargo MC, Bravo JC, Delgado AG, Romero-Gallo J, Yepez MC, Realpe JL, Schneider BG, Morgan DR, Peek RM, Correa P, Wilson KT, Piazuelo MB. Dynamics of Helicobacter pylori infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial. Gut. 2018;67:1239-1246. [PMID: 28647684 DOI: 10.1136/gutjnl-2016-311685] [Cited by in Crossref: 71] [Cited by in F6Publishing: 65] [Article Influence: 14.2] [Reference Citation Analysis]
103 Gawron AJ, Shah SC, Altayar O, Davitkov P, Morgan D, Turner K, Mustafa RA. AGA Technical Review on Gastric Intestinal Metaplasia-Natural History and Clinical Outcomes. Gastroenterology 2020;158:705-731.e5. [PMID: 31816300 DOI: 10.1053/j.gastro.2019.12.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 8.3] [Reference Citation Analysis]
104 Padmanabhan N, Kyon HK, Boot A, Lim K, Srivastava S, Chen S, Wu Z, Lee HO, Mukundan VT, Chan C, Chan YK, Xuewen O, Pitt JJ, Isa ZFA, Xing M, Lee MH, Tan ALK, Ting SHW, Luftig MA, Kappei D, Kruger WD, Bian J, Ho YS, Teh M, Rozen SG, Tan P. Highly recurrent CBS epimutations in gastric cancer CpG island methylator phenotypes and inflammation. Genome Biol 2021;22:167. [PMID: 34074348 DOI: 10.1186/s13059-021-02375-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Banks M, Graham D, Jansen M, Gotoda T, Coda S, di Pietro M, Uedo N, Bhandari P, Pritchard DM, Kuipers EJ, Rodriguez-Justo M, Novelli MR, Ragunath K, Shepherd N, Dinis-Ribeiro M. British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut. 2019;68:1545-1575. [PMID: 31278206 DOI: 10.1136/gutjnl-2018-318126] [Cited by in Crossref: 113] [Cited by in F6Publishing: 109] [Article Influence: 37.7] [Reference Citation Analysis]
106 Tong Y, Wu Y, Song Z, Yu Y, Yu X. The potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in China: a diagnostic clinical research. BMC Gastroenterol 2017;17:88. [PMID: 28728545 DOI: 10.1186/s12876-017-0641-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
107 Ward LS. Immune response in thyroid cancer: widening the boundaries. Scientifica (Cairo) 2014;2014:125450. [PMID: 25328756 DOI: 10.1155/2014/125450] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
108 Kosunen TU, Pukkala E, Sarna S, Seppälä K, Aromaa A, Knekt P, Rautelin H. Gastric cancers in Finnish patients after cure of Helicobacter pylori infection: A cohort study. Int J Cancer. 2011;128:433-439. [PMID: 20309944 DOI: 10.1002/ijc.25337] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
109 Agréus L, Kuipers EJ, Kupcinskas L, Malfertheiner P, Di Mario F, Leja M, Mahachai V, Yaron N, van Oijen M, Perez Perez G, Rugge M, Ronkainen J, Salaspuro M, Sipponen P, Sugano K, Sung J. Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol 2012;47:136-47. [PMID: 22242613 DOI: 10.3109/00365521.2011.645501] [Cited by in Crossref: 82] [Cited by in F6Publishing: 74] [Article Influence: 8.2] [Reference Citation Analysis]
110 Iwagami H, Ishihara R, Nakagawa K, Ohmori M, Matsuno K, Inoue S, Arao M, Iwatsubo T, Nakahira H, Matsuura N, Shichijo S, Maekawa A, Takashi K, Yamamoto S, Takeuchi Y, Higashino K, Uedo N, Miyashiro I. Natural history of early gastric cancer: series of 21 cases. Endosc Int Open 2019;7:E43-8. [PMID: 30648138 DOI: 10.1055/a-0746-3329] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
111 Yoon SB, Park JM, Lim CH, Kim JS, Cho YK, Lee BI, Lee IS, Kim SW, Choi MG. Incidence of gastric cancer after endoscopic resection of gastric adenoma. Gastrointest Endosc 2016;83:1176-83. [PMID: 26522370 DOI: 10.1016/j.gie.2015.10.024] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
112 Pan H, Fang C, He L, Li H, Liu L, Wang C, Chen J. Risk of multiple early gastric cancers in a patient with precursor lesions and endoscopic surveillance for 7 years: A case report. Medicine (Baltimore) 2019;98:e15686. [PMID: 31145282 DOI: 10.1097/MD.0000000000015686] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
113 Song H, Ekheden IG, Zheng Z, Ericsson J, Nyrén O, Ye W. Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population. BMJ. 2015;351:h3867. [PMID: 26215280 DOI: 10.1136/bmj.h3867] [Cited by in Crossref: 99] [Cited by in F6Publishing: 88] [Article Influence: 14.1] [Reference Citation Analysis]
114 Lim JH, Song JH, Chung SJ, Chung GE, Kim JS. Characteristics of interval gastric neoplasms detected within two years after negative screening endoscopy among Koreans. BMC Cancer 2021;21:218. [PMID: 33653298 DOI: 10.1186/s12885-021-07929-y] [Reference Citation Analysis]
115 den Hollander WJ, Holster IL, den Hoed CM, Capelle LG, Tang TJ, Anten M, Prytz-berset I, Witteman EM, ter Borg F, Hartog GD, Bruno MJ, Peppelenbosch MP, Lesterhuis W, Doukas M, Kuipers EJ, Spaander MCW. Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions. Gut 2019;68:585-93. [DOI: 10.1136/gutjnl-2017-314498] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 10.0] [Reference Citation Analysis]
116 Baek DH, Kim GH, Park DY, Lee BE, Jeon HK, Lim W, Song GA. Gastric epithelial dysplasia: characteristics and long-term follow-up results after endoscopic resection according to morphological categorization. BMC Gastroenterol 2015;15:17. [PMID: 25886985 DOI: 10.1186/s12876-015-0249-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
117 Li D, Zhao L, Li Y, Kang X, Zhang S. Gastro-Protective Effects of Calycosin Against Precancerous Lesions of Gastric Carcinoma in Rats. Drug Des Devel Ther 2020;14:2207-19. [PMID: 32606591 DOI: 10.2147/DDDT.S247958] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
118 Xiao S, Lu H, Xue Y, Cui R, Meng L, Jin Z, Yin Z, Zhou L. Long-Term Outcome of Gastric Mild-Moderate Dysplasia: A Real-World Clinical Experience. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01145-9. [PMID: 34718170 DOI: 10.1016/j.cgh.2021.10.032] [Reference Citation Analysis]
119 Yoon H, Kim N. Diagnosis and management of high risk group for gastric cancer. Gut Liver. 2015;9:5-17. [PMID: 25547086 DOI: 10.5009/gnl14118] [Cited by in Crossref: 121] [Cited by in F6Publishing: 106] [Article Influence: 17.3] [Reference Citation Analysis]
120 Rao W, Xie M, Zang YJ, Zhi KQ. Chronic atrophic gastritis and Helicobacter pylori infection status in liver transplant recipients. Transpl Infect Dis 2021;23:e13513. [PMID: 33207018 DOI: 10.1111/tid.13513] [Reference Citation Analysis]
121 Chiu PW, Ng EK, To KF, Teoh AY, Lam CC, Chan FK, Sung JJ, Lau JY. Recognition of goblet cells upon endocytoscopy indicates the presence of gastric intestinal metaplasia. Dig Endosc. 2014;26:52-56. [PMID: 23551261 DOI: 10.1111/den.12050] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
122 Lee YC, Liou JM, Wu MS, Wu CY, Lin JT. Eradication of helicobacter pylori to prevent gastroduodenal diseases: hitting more than one bird with the same stone. Therap Adv Gastroenterol. 2008;1:111-120. [PMID: 21180520 DOI: 10.1177/1756283x08094880] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
123 Noto JM, Gaddy JA, Lee JY, Piazuelo MB, Friedman DB, Colvin DC, Romero-Gallo J, Suarez G, Loh J, Slaughter JC. Iron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humans. J Clin Invest. 2013;123:479-492. [PMID: 23257361 DOI: 10.1172/jci6437364373] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
124 Young E, Philpott H, Singh R. Endoscopic diagnosis and treatment of gastric dysplasia and early cancer: Current evidence and what the future may hold. World J Gastroenterol 2021; 27(31): 5126-5151 [PMID: 34497440 DOI: 10.3748/wjg.v27.i31.5126] [Reference Citation Analysis]
125 Fang J, Du YQ, Liu WZ, Ren JL, Li YQ, Chen XY, Lv NH, Chen YX, Lv B; Chinese Society of Gastroenterology, Chinese Medical Association. Chinese consensus on chronic gastritis (2017, Shanghai): 2017 Chinese consensus on CG. Journal of Digestive Diseases 2018;19:182-203. [DOI: 10.1111/1751-2980.12593] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
126 Areia M, Dinis-Ribeiro M, Rocha Gonçalves F. Cost-utility analysis of endoscopic surveillance of patients with gastric premalignant conditions. Helicobacter. 2014;19:425-436. [PMID: 25164596 DOI: 10.1111/hel.12150] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
127 Zullo A, Hassan C, Romiti A, Giusto M, Guerriero C, Lorenzetti R, Campo SM, Tomao S. Follow-up of intestinal metaplasia in the stomach: When, how and why. World J Gastrointest Oncol 2012; 4(3): 30-36 [PMID: 22468181 DOI: 10.4251/wjgo.v4.i3.30] [Cited by in CrossRef: 59] [Cited by in F6Publishing: 50] [Article Influence: 5.9] [Reference Citation Analysis]
128 Reddy KM, Chang JI, Shi JM, Wu BU. Risk of Gastric Cancer Among Patients With Intestinal Metaplasia of the Stomach in a US Integrated Health Care System. Clin Gastroenterol Hepatol. 2016;14:1420-1425. [PMID: 27317852 DOI: 10.1016/j.cgh.2016.05.045] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 6.8] [Reference Citation Analysis]
129 Bosques-Padilla FJ, Remes-Troche JM, González-Huezo MS, Pérez-Pérez G, Torres-López J, Abdo-Francis JM, Bielsa-Fernandez MV, Camargo MC, Esquivel-Ayanegui F, Garza-González E, Hernández-Guerrero AI, Herrera-Goepfert R, Huerta-Iga FM, Leal-Herrera Y, Lopéz-Colombo A, Ortiz-Olvera NX, Riquelme-Pérez A, Sampieri CL, Uscanga-Domínguez LF, Velarde-Ruiz Velasco JA. The fourth Mexican consensus on Helicobacter pylori. Rev Gastroenterol Mex (Engl Ed) 2018;83:325-41. [PMID: 29941237 DOI: 10.1016/j.rgmx.2018.05.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
130 Chen M, Liu C, Huan H, Hu RW, Wu H, Deng K. A comparative study on Helicobacter pylori infection in Tibetan and Han people from Tibet and Sichuan province. Shijie Huaren Xiaohua Zazhi 2018; 26(23): 1402-1407 [DOI: 10.11569/wcjd.v26.i23.1402] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
131 Goo JJ, Choi CW, Kang DH, Kim HW, Park SB, Cho M, Hwang SH, Lee SH. Risk factors associated with diagnostic discrepancy of gastric indefinite neoplasia: Who need en bloc resection? Surg Endosc 2015;29:3761-7. [PMID: 25894444 DOI: 10.1007/s00464-015-4151-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
132 Păun I, Costin AI, Constantin VD, Lomaca I, Ianoşi NG, Socea B, Tutunaru CV, Zlatian OM, Ianoşi SL, Neagoe CD, Crafciuc AV, Stancu MI. Gastric cancer - histopathological correlations between tumor and non-tumor gastric mucosa changes. Rom J Morphol Embryol 2020;61:1129-41. [PMID: 34171062 DOI: 10.47162/RJME.61.4.15] [Reference Citation Analysis]
133 Wang L, Chen S, Xue M, Zhong J, Wang X, Gan L, Lam EK, Liu X, Zhang J, Zhou T. Homeobox D10 gene, a candidate tumor suppressor, is downregulated through promoter hypermethylation and associated with gastric carcinogenesis. Mol Med. 2012;18:389-400. [PMID: 22160393 DOI: 10.2119/molmed.2011.00172] [Cited by in Crossref: 30] [Cited by in F6Publishing: 38] [Article Influence: 3.0] [Reference Citation Analysis]
134 Mommersteeg MC, Nieuwenburg SAV, den Hollander WJ, Holster L, den Hoed CM, Capelle LG, Tang TJ, Anten MP, Prytz-Berset I, Witteman EM, Ter Borg F, Burger JPW, Doukas M, Bruno MJ, Peppelenbosch MP, Fuhler GM, Kuipers EJ, Spaander MCW. Accuracy of upper endoscopies with random biopsies to identify patients with gastric premalignant lesions who can safely be exempt from surveillance. Gastric Cancer 2021;24:680-90. [PMID: 33616776 DOI: 10.1007/s10120-020-01149-2] [Reference Citation Analysis]
135 Quach DT, Hiyama T, Le HM, Nguyen TS, Gotoda T. Use of endoscopic assessment of gastric atrophy for gastric cancer risk stratification to reduce the need for gastric mapping. Scand J Gastroenterol 2020;55:402-7. [PMID: 32223458 DOI: 10.1080/00365521.2020.1740777] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
136 Li J, Ren M, Yang J, Zhao Y, Li Y, Zhang D, Wu F, Zhang Z, Lu X, Ren L, He S, Lu G. Screening value for gastrointestinal lesions of magnetic-controlled capsule endoscopy in asymptomatic individuals. J Gastroenterol Hepatol 2021;36:1267-75. [PMID: 33000488 DOI: 10.1111/jgh.15282] [Reference Citation Analysis]
137 Setia N, Lauwers GY. Gastric dysplasia: update and practical approach. Diagnostic Histopathology 2015;21:312-22. [DOI: 10.1016/j.mpdhp.2015.06.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
138 Liu H, Li PW, Yang WQ, Mi H, Pan JL, Huang YC, Hou ZK, Hou QK, Luo Q, Liu FB. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs. BMC Cancer. 2019;19:129. [PMID: 30736753 DOI: 10.1186/s12885-019-5328-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
139 Palmela C, Fonseca C, Faria R, Baptista RB, Ribeiro S, Ferreira AO. Increased risk for metachronous gastric adenocarcinoma following gastric MALT lymphoma-A US population-based study. United European Gastroenterol J 2017;5:473-8. [PMID: 28588876 DOI: 10.1177/2050640616671643] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
140 Chapelle N, Jirka I, Péron M, Quénéhervé L, Cauchin E, Touchefeu Y, Coron E, Mosnier JF, Matysiak-Budnik T. Evaluation of a Phone Call Reminder Strategy in the Surveillance of Patients with Gastric Precancerous Lesions Lost to Follow-Up. Gastrointest Tumors 2020;7:110-6. [PMID: 33173774 DOI: 10.1159/000508873] [Reference Citation Analysis]
141 Arieira C, Boal Carvalho P, Dias de Castro F, Cotter J. Esophagogastroduodenoscopy Findings in Patients on the Waiting List for Bariatric Surgery. GE Port J Gastroenterol 2019;26:389-95. [PMID: 31832493 DOI: 10.1159/000495770] [Reference Citation Analysis]
142 Gupta N, Bansal A, Wani SB, Gaddam S, Rastogi A, Sharma P. Endoscopy for upper GI cancer screening in the general population: a cost-utility analysis. Gastrointest Endosc. 2011;74:610-624.e2. [PMID: 21741639 DOI: 10.1016/j.gie.2011.05.001] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 5.0] [Reference Citation Analysis]
143 Kato M. Diagnosis and therapies for gastric non-invasive neoplasia. World J Gastroenterol 2015; 21(44): 12513-12518 [PMID: 26640329 DOI: 10.3748/wjg.v21.i44.12513] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
144 Yao K, Uedo N, Kamada T, Hirasawa T, Nagahama T, Yoshinaga S, Oka M, Inoue K, Mabe K, Yao T, Yoshida M, Miyashiro I, Fujimoto K, Tajiri H. Guidelines for endoscopic diagnosis of early gastric cancer. Dig Endosc. 2020;32:663-698. [PMID: 32275342 DOI: 10.1111/den.13684] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
145 Yun CY, Kim N, Lee J, Lee JY, Hwang YJ, Lee HS, Yoon H, Shin CM, Park YS, Kim JW, Lee DH. Usefulness of OLGA and OLGIM system not only for intestinal type but also for diffuse type of gastric cancer, and no interaction among the gastric cancer risk factors. Helicobacter. 2018;23:e12542. [PMID: 30303591 DOI: 10.1111/hel.12542] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
146 Tong Y, Wang H, Zhao Y, He X, Xu H, Li H, Shuai P, Gong L, Wu H, Xu H, Luo Y, Wang D, Liu S, Song Z. Diagnostic Value of Serum Pepsinogen Levels for Screening Gastric Cancer and Atrophic Gastritis in Asymptomatic Individuals: A Cross-Sectional Study. Front Oncol 2021;11:652574. [PMID: 34504781 DOI: 10.3389/fonc.2021.652574] [Reference Citation Analysis]
147 Hugen S, Thomas RE, German AJ, Burgener IA, Mandigers PJJ. Gastric carcinoma in canines and humans, a review. Vet Comp Oncol 2017;15:692-705. [PMID: 27549077 DOI: 10.1111/vco.12249] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
148 Sayed IM, Sahan AZ, Venkova T, Chakraborty A, Mukhopadhyay D, Bimczok D, Beswick EJ, Reyes VE, Pinchuk I, Sahoo D, Ghosh P, Hazra TK, Das S. Helicobacter pylori infection downregulates the DNA glycosylase NEIL2, resulting in increased genome damage and inflammation in gastric epithelial cells. J Biol Chem 2020;295:11082-98. [PMID: 32518160 DOI: 10.1074/jbc.RA119.009981] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 8.5] [Reference Citation Analysis]
149 Fassan M, Pizzi M, Farinati F, Nitti D, Zagonel V, Genta RM, Rugge M. Lesions Indefinite for Intraepithelial Neoplasia and OLGA Staging for Gastric Atrophy. Am J Clin Pathol 2012;137:727-32. [DOI: 10.1309/ajcpeu41htgxsjdq] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
150 Zullo A, Hassan C. How harmful is the presence of intestinal metaplasia in the stomach? Gastroenterology. 2009;136:1461-1462; author reply 1462. [PMID: 19245871 DOI: 10.1053/j.gastro.2008.11.064] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
151 Kim YI, Kook MC, Cho SJ, Lee JY, Kim CG, Joo J, Choi IJ. Effect of biopsy site on detection of gastric cancer high-risk groups by OLGA and OLGIM stages. Helicobacter. 2017;22. [PMID: 28940945 DOI: 10.1111/hel.12442] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
152 Kinoshita H, Hayakawa Y, Koike K. Metaplasia in the Stomach-Precursor of Gastric Cancer? Int J Mol Sci. 2017;18:pii: E2063. [PMID: 28953255 DOI: 10.3390/ijms18102063] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 5.6] [Reference Citation Analysis]
153 Zhao H, Wen J, Dong X, He R, Gao C, Zhang W, Zhang Z, Shen L. Identification of AQP3 and CD24 as biomarkers for carcinogenesis of gastric intestinal metaplasia. Oncotarget 2017;8:63382-91. [PMID: 28968998 DOI: 10.18632/oncotarget.18817] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
154 Wei N, Zhou M, Lei S, Zhong Z, Shi R. A meta-analysis and systematic review on subtypes of gastric intestinal metaplasia and neoplasia risk. Cancer Cell Int 2021;21:173. [PMID: 33731114 DOI: 10.1186/s12935-021-01869-0] [Reference Citation Analysis]
155 Venerito M, Varbanova M, Röhl F, Reinhold D, Frauenschläger K, Jechorek D, Weigt J, Link A, Malfertheiner P. Oxyntic gastric atrophy in Helicobacter pylori gastritis is distinct from autoimmune gastritis. J Clin Pathol 2016;69:677-85. [DOI: 10.1136/jclinpath-2015-203405] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
156 Chen Y, Dang Y, Sang H, Wang X, Chen M, Lu D, Zhang G. Establishment and validation of a model to determine the progression risk of low grade intraepithelial neoplasia. Surg Endosc 2021;35:1551-7. [PMID: 32424624 DOI: 10.1007/s00464-020-07531-6] [Reference Citation Analysis]
157 Bornschein J, Malfertheiner P. Gastric carcinogenesis. Langenbecks Arch Surg. 2011;396:729-742. [PMID: 21611816 DOI: 10.1007/s00423-011-0810-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
158 Park JM, Huo SM, Lee HH, Lee BI, Song HJ, Choi MG. Longer Observation Time Increases Proportion of Neoplasms Detected by Esophagogastroduodenoscopy. Gastroenterology. 2017;153:460-469. e1. [PMID: 28501581 DOI: 10.1053/j.gastro.2017.05.009] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 7.4] [Reference Citation Analysis]
159 Teh JL, Tan JR, Lau LJF, Saxena N, Salim A, Tay A, Shabbir A, Chung S, Hartman M, Bok-yan So J. Longer Examination Time Improves Detection of Gastric Cancer During Diagnostic Upper Gastrointestinal Endoscopy. Clinical Gastroenterology and Hepatology 2015;13:480-487.e2. [DOI: 10.1016/j.cgh.2014.07.059] [Cited by in Crossref: 73] [Cited by in F6Publishing: 62] [Article Influence: 10.4] [Reference Citation Analysis]
160 Tsai MC, Wang CC, Lee HL, Peng CM, Yang TW, Chen HY, Sung WW, Lin CC. Health disparities are associated with gastric cancer mortality-to-incidence ratios in 57 countries. World J Gastroenterol 2017; 23(44): 7881-7887 [PMID: 29209129 DOI: 10.3748/wjg.v23.i44.7881] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
161 González CA, Sanz-Anquela JM, Gisbert JP, Correa P. Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence. Int J Cancer. 2013;133:1023-1032. [PMID: 23280711 DOI: 10.1002/ijc.28003] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 6.3] [Reference Citation Analysis]
162 Cho SJ, Choi IJ, Kim CG, Kook MC, Lee JY, Kim BC, Ryu KH, Nam SY, Kim YW. Risk factors associated with gastric cancer in patients with a duodenal ulcer. Helicobacter. 2010;15:516-523. [PMID: 21073608 DOI: 10.1111/j.1523-5378.2010.00805.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
163 Tiwari AK, Laird-Fick HS, Wali RK, Roy HK. Surveillance for gastrointestinal malignancies. World J Gastroenterol 2012; 18(33): 4507-4516 [PMID: 22969223 DOI: 10.3748/wjg.v18.i33.4507] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
164 Correia M, Machado JC, Ristimäki A. Basic aspects of gastric cancer. Helicobacter. 2009;14 Suppl 1:36-40. [PMID: 19712166 DOI: 10.1111/j.1523-5378.2009.00696.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
165 Kato M, Nishida T, Yamamoto K, Hayashi S, Kitamura S, Yabuta T, Yoshio T, Nakamura T, Komori M, Kawai N, Nishihara A, Nakanishi F, Nakahara M, Ogiyama H, Kinoshita K, Yamada T, Iijima H, Tsujii M, Takehara T. Scheduled endoscopic surveillance controls secondary cancer after curative endoscopic resection for early gastric cancer: a multicentre retrospective cohort study by Osaka University ESD study group. Gut. 2013;62:1425-1432. [PMID: 22914298 DOI: 10.1136/gutjnl-2011-301647] [Cited by in Crossref: 134] [Cited by in F6Publishing: 135] [Article Influence: 13.4] [Reference Citation Analysis]
166 Yue B, Cui R, Zheng R, Jin W, Song C, Bao T, Wang M, Yu F, Zhao E. Essential role of ALKBH5-mediated RNA demethylation modification in bile acid-induced gastric intestinal metaplasia. Mol Ther Nucleic Acids 2021;26:458-72. [PMID: 34631277 DOI: 10.1016/j.omtn.2021.08.019] [Reference Citation Analysis]
167 Lochhead P, El-Omar EM. Molecular Predictors of Gastric Neoplastic Progression. Cancer Cell 2018;33:9-11. [PMID: 29316435 DOI: 10.1016/j.ccell.2017.12.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
168 Oh JH, Rhyu MG, Kim SI, Yun MR, Shin JH, Hong SJ. Gastric Mucosal Atrophy Impedes Housekeeping Gene Methylation in Gastric Cancer Patients. Cancer Res Treat 2019;51:267-79. [PMID: 29747491 DOI: 10.4143/crt.2018.085] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
169 Capelle LG, de Vries AC, Haringsma J, Ter Borg F, de Vries RA, Bruno MJ, van Dekken H, Meijer J, van Grieken NC, Kuipers EJ. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc. 2010;71:1150-1158. [PMID: 20381801 DOI: 10.1016/j.gie.2009.12.029] [Cited by in Crossref: 241] [Cited by in F6Publishing: 225] [Article Influence: 20.1] [Reference Citation Analysis]
170 Lahner E, Carabotti M, Annibale B. Treatment of Helicobacter pylori infection in atrophic gastritis. World J Gastroenterol 2018; 24(22): 2373-2380 [PMID: 29904244 DOI: 10.3748/wjg.v24.i22.2373] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
171 Amieva M, Peek RM. Pathobiology of Helicobacter pylori-induced gastric cancer. Gastroenterology. 2016;150:64-78. [PMID: 26385073 DOI: 10.1053/j.gastro.2015.09.004] [Cited by in Crossref: 335] [Cited by in F6Publishing: 302] [Article Influence: 47.9] [Reference Citation Analysis]
172 Ryu DG, Choi CW, Kang DH, Kim HW, Park SB, Kim SJ, Nam HS. Pathologic outcomes of endoscopic submucosal dissection for gastric epithelial neoplasia. Medicine (Baltimore). 2018;97:e11802. [PMID: 30113468 DOI: 10.1097/md.0000000000011802] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
173 Abadir A, Streutker C, Brezden-Masley C, Grin A, Kim YI. Intestinal metaplasia and the risk of gastric cancer in an immigrant asian population. Clin Med Insights Gastroenterol 2012;5:43-50. [PMID: 24833933 DOI: 10.4137/CGast.S10070] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
174 Yeh JM, Hur C, Ward Z, Schrag D, Goldie SJ. Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis. Gut. 2016;65:563-574. [PMID: 25779597 DOI: 10.1136/gutjnl-2014-308588] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 7.3] [Reference Citation Analysis]
175 Isajevs S, Savcenko S, Liepniece-Karele I, Piazuelo MB, Kikuste I, Tolmanis I, Vanags A, Gulbe I, Mezmale L, Samentaev D, Tazedinov A, Samsutdinov R, Belihina T, Igissinov N, Leja M. High-risk individuals for gastric cancer would be missed for surveillance without subtyping of intestinal metaplasia. Virchows Arch 2021. [PMID: 33990867 DOI: 10.1007/s00428-021-03116-3] [Reference Citation Analysis]
176 Noto JM, Gaddy JA, Lee JY, Piazuelo MB, Friedman DB, Colvin DC, Romero-Gallo J, Suarez G, Loh J, Slaughter JC. Iron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humans. J Clin Invest. 2013;123:479-492. [PMID: 23257361 DOI: 10.1172/jci64373] [Cited by in Crossref: 109] [Cited by in F6Publishing: 88] [Article Influence: 10.9] [Reference Citation Analysis]
177 Zhou Y, Li HY, Zhang JJ, Chen XY, Ge ZZ, Li XB. Operative link on gastritis assessment stage is an appropriate predictor of early gastric cancer. World J Gastroenterol 2016; 22(13): 3670-3678 [PMID: 27053859 DOI: 10.3748/wjg.v22.i13.3670] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
178 de Vries AC, Haringsma J, de Vries RA, Ter Borg F, van Grieken NC, Meijer GA, van Dekken H, Kuipers EJ. Biopsy strategies for endoscopic surveillance of pre-malignant gastric lesions. Helicobacter. 2010;15:259-264. [PMID: 20633186 DOI: 10.1111/j.1523-5378.2010.00760.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 3.7] [Reference Citation Analysis]
179 Lahner E, Bernardini G, Santucci A, Annibale B. Helicobacter pylori immunoproteomics in gastric cancer and gastritis of the carcinoma phenotype. Expert Rev Proteomics. 2010;7:239-248. [PMID: 20377390 DOI: 10.1586/epr.10.5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
180 Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O'Connor A, Pereira C, Pimentel-Nunes P, Correia R, Ensari A, Dumonceau JM, Machado JC, Macedo G, Malfertheiner P, Matysiak-Budnik T, Megraud F, Miki K, O'Morain C, Peek RM, Ponchon T, Ristimaki A, Rembacken B, Carneiro F, Kuipers EJ; European Society of Gastrointestinal Endoscopy., European Helicobacter Study Group., European Society of Pathology., Sociedade Portuguesa de Endoscopia Digestiva. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012;44:74-94. [PMID: 22198778 DOI: 10.1055/s-0031-1291491] [Cited by in Crossref: 389] [Cited by in F6Publishing: 344] [Article Influence: 35.4] [Reference Citation Analysis]
181 Shichijo S, Hirata Y, Niikura R, Hayakawa Y, Yamada A, Koike K. Association between gastric cancer and the Kyoto classification of gastritis. J Gastroenterol Hepatol. 2017;32:1581-1586. [PMID: 28217843 DOI: 10.1111/jgh.13764] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
182 Da B, Jani N, Gupta N, Jayaram P, Kankotia R, Yao Yu C, Dinis-Ribeiro M, Buxbaum J. High-risk symptoms do not predict gastric cancer precursors. Helicobacter 2019;24:e12548. [PMID: 30412322 DOI: 10.1111/hel.12548] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
183 Kim GH, Bang SJ, Ende AR, Hwang JH. Is screening and surveillance for early detection of gastric cancer needed in Korean Americans? Korean J Intern Med 2015;30:747-58. [PMID: 26552450 DOI: 10.3904/kjim.2015.30.6.747] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
184 Choi IJ. Current evidence of effects of Helicobacter pylori eradication on prevention of gastric cancer. Korean J Intern Med. 2013;28:525-537. [PMID: 24009446 DOI: 10.3904/kjim.2013.28.5.525] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
185 Sung JK. Diagnosis and management of gastric dysplasia. Korean J Intern Med 2016;31:201-9. [PMID: 26932397 DOI: 10.3904/kjim.2016.021] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 6.7] [Reference Citation Analysis]
186 Radulescu S, Ridgway RA, Cordero J, Athineos D, Salgueiro P, Poulsom R, Neumann J, Jung A, Patel S, Woodgett J. Acute WNT signalling activation perturbs differentiation within the adult stomach and rapidly leads to tumour formation. Oncogene. 2013;32:2048-2057. [PMID: 22665058 DOI: 10.1038/onc.2012.224] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 3.4] [Reference Citation Analysis]
187 de Jonge PJ, van Blankenstein M, Looman CW, Casparie MK, Meijer GA, Kuipers EJ. Risk of colorectal cancer in patients with Barrett's esophagus: A Dutch population-based study. Am J Gastroenterol 2010;105:77-83. [PMID: 19724268 DOI: 10.1038/ajg.2009.503] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
188 Wang L, Huang W, Du J, Chen Y, Yang J. Diagnostic yield of the light blue crest sign in gastric intestinal metaplasia: a meta-analysis. PLoS One. 2014;9:e92874. [PMID: 24658503 DOI: 10.1371/journal.pone.0092874] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
189 White JR, Sami SS, Reddiar D, Mannath J, Ortiz-Fernández-Sordo J, Beg S, Scott R, Thiagarajan P, Ahmad S, Parra-Blanco A, Kasi M, Telakis E, Sultan AA, Davis J, Figgins A, Kaye P, Robinson K, Atherton JC, Ragunath K. Narrow band imaging and serology in the assessment of premalignant gastric pathology. Scand J Gastroenterol 2018;53:1611-8. [PMID: 30600732 DOI: 10.1080/00365521.2018.1542455] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
190 Asaka M. A new approach for elimination of gastric cancer deaths in Japan. Int J Cancer. 2013;132:1272-1276. [PMID: 23180638 DOI: 10.1002/ijc.27965] [Cited by in Crossref: 84] [Cited by in F6Publishing: 73] [Article Influence: 8.4] [Reference Citation Analysis]
191 Lahner E, Zullo A, Hassan C, Perri F, Dinis-Ribeiro M, Esposito G, Di Giulio E, Buscarini E, Bianco MA, De Boni M. Detection of gastric precancerous conditions in daily clinical practice: a nationwide survey. Helicobacter. 2014;19:417-424. [PMID: 25231208 DOI: 10.1111/hel.12149] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
192 Cunha LL, Marcello MA, Vassallo J, Ward LS. Differentiated thyroid carcinomas and their B7H1 shield. Future Oncol 2013;9:1417-9. [PMID: 23651132 DOI: 10.2217/fon.13.89] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
193 van der Post RS, van Dieren J, Grelack A, Hoogerbrugge N, van der Kolk LE, Snaebjornsson P, Lansdorp-Vogelaar I, van Krieken JH, Bisseling TM, Cats A. Outcomes of screening gastroscopy in first-degree relatives of patients fulfilling hereditary diffuse gastric cancer criteria. Gastrointest Endosc. 2018;87:397-404.e2. [PMID: 28455161 DOI: 10.1016/j.gie.2017.04.016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
194 Zeng J, Yan R, Pan H, You F, Cai T, Liu W, Zheng C, Zhao Z, Gong D, Chen L, Zhang Y. Weipixiao attenuate early angiogenesis in rats with gastric precancerous lesions. BMC Complement Altern Med 2018;18:250. [PMID: 30200948 DOI: 10.1186/s12906-018-2309-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
195 Rugge M, Genta RM, Di Mario F, El-Omar EM, El-Serag HB, Fassan M, Hunt RH, Kuipers EJ, Malfertheiner P, Sugano K, Graham DY. Gastric Cancer as Preventable Disease. Clin Gastroenterol Hepatol. 2017;15:1833-1843. [PMID: 28532700 DOI: 10.1016/j.cgh.2017.05.023] [Cited by in Crossref: 93] [Cited by in F6Publishing: 91] [Article Influence: 18.6] [Reference Citation Analysis]
196 Shao L, Li P, Ye J, Chen J, Han Y, Cai J, Lu X. Risk of gastric cancer among patients with gastric intestinal metaplasia. Int J Cancer. 2018;. [PMID: 29707766 DOI: 10.1002/ijc.31571] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
197 Ryu DG, Choi CW, Kang DH, Kim HW, Park SB, Kim SJ, Nam HS. Clinical outcomes of endoscopic submucosa dissection for high-grade dysplasia from endoscopic forceps biopsy. Gastric Cancer 2017;20:671-8. [PMID: 27822683 DOI: 10.1007/s10120-016-0665-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
198 Kalkan IH, Sapmaz F, Güliter S, Atasoy P. Severe gastritis decreases success rate of Helicobacter pylori eradication. Wien Klin Wochenschr 2016;128:329-34. [PMID: 26637331 DOI: 10.1007/s00508-015-0896-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
199 de Vries AC, Kuipers EJ, Rauws EA. Helicobacter pylori eradication and gastric cancer: when is the horse out of the barn? Am J Gastroenterol. 2009;104:1342-1345. [PMID: 19491846 DOI: 10.1038/ajg.2008.15] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 4.2] [Reference Citation Analysis]
200 Chapelle N, Péron M, Quénéhervé L, Bourget A, Leroy M, Touchefeu Y, Cauchin E, Coron E, Mosnier JF, Matysiak-Budnik T. Long-Term Follow-up of Gastric Precancerous Lesions in a Low GC Incidence Area. Clin Transl Gastroenterol 2020;11:e00237. [PMID: 33512802 DOI: 10.14309/ctg.0000000000000237] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
201 Nakanishi R, Shimizu T, Kumagai K, Takai A, Marusawa H. Genetic Pathogenesis of Inflammation-Associated Cancers in Digestive Organs. Pathogens 2021;10:453. [PMID: 33918902 DOI: 10.3390/pathogens10040453] [Reference Citation Analysis]
202 Cheng XJ, Lin JC, Tu SP. Etiology and Prevention of Gastric Cancer. Gastrointest Tumors 2016;3:25-36. [PMID: 27722154 DOI: 10.1159/000443995] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 9.3] [Reference Citation Analysis]
203 Nestegard O, Johnsen KM, Sørbye SW, Halvorsen FA, Tønnessen T, Paulssen EJ, Melby KK, Goll R, Florholmen J. Clinical characterization of Helicobacter pylori infected patients 15 years after unsuccessful eradication. PLoS One 2020;15:e0238944. [PMID: 32966303 DOI: 10.1371/journal.pone.0238944] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
204 Saumoy M, Schneider Y, Shen N, Kahaleh M, Sharaiha RZ, Shah SC. Cost Effectiveness of Gastric Cancer Screening According to Race and Ethnicity. Gastroenterology 2018;155:648-60. [DOI: 10.1053/j.gastro.2018.05.026] [Cited by in Crossref: 53] [Cited by in F6Publishing: 41] [Article Influence: 13.3] [Reference Citation Analysis]
205 Smolka AJ, Schubert ML. Helicobacter pylori-Induced Changes in Gastric Acid Secretion and Upper Gastrointestinal Disease. Curr Top Microbiol Immunol 2017;400:227-52. [PMID: 28124156 DOI: 10.1007/978-3-319-50520-6_10] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
206 Nishida T, Tsutsui S, Kato M, Inoue T, Yamamoto S, Hayashi Y, Akasaka T, Yamada T, Shinzaki S, Iijima H, Tsujii M, Takehara T. Treatment strategy for gastric non-invasive intraepithelial neoplasia diagnosed by endoscopic biopsy. World J Gastrointest Pathophysiol 2011; 2(6): 93-99 [PMID: 22180842 DOI: 10.4291/wjgp.v2.i6.93] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
207 Villarreal-Calderon R, Luévano-González A, Aragón-Flores M, Zhu H, Yuan Y, Xiang Q, Yan B, Stoll KA, Cross JV, Iczkowski KA, Mackinnon AC Jr. Antral atrophy, intestinal metaplasia, and preneoplastic markers in Mexican children with Helicobacter pylori-positive and Helicobacter pylori-negative gastritis. Ann Diagn Pathol 2014;18:129-35. [PMID: 24656654 DOI: 10.1016/j.anndiagpath.2014.02.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
208 Zhu F, Loh M, Hill J, Lee S, Koh KX, Lai KW, Salto-Tellez M, Iacopetta B, Yeoh KG, Soong R; Singapore Gastric Cancer Consortium. Genetic factors associated with intestinal metaplasia in a high risk Singapore-Chinese population: a cohort study. BMC Gastroenterol 2009;9:76. [PMID: 19822020 DOI: 10.1186/1471-230X-9-76] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
209 Ang TL, Kwek ABE. Advanced Imaging for Characterization of Intestinal Metaplasia. Video Journal and Encyclopedia of GI Endoscopy 2013;1:110-1. [DOI: 10.1016/s2212-0971(13)70048-7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
210 Liu X, Zhang M, Luo R, Mo K, He X. Significance of pepsinogen in screening for gastric intestinal metaplasia in Guangdong, China. J Int Med Res 2021;49:300060521990495. [PMID: 33631996 DOI: 10.1177/0300060521990495] [Reference Citation Analysis]
211 Rugge M, Capelle LG, Fassan M. Individual risk stratification of gastric cancer: evolving concepts and their impact on clinical practice. Best Pract Res Clin Gastroenterol. 2014;28:1043-1053. [PMID: 25439070 DOI: 10.1016/j.bpg.2014.09.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
212 Akbari M, Tabrizi R, Kardeh S, Lankarani KB. Gastric cancer in patients with gastric atrophy and intestinal metaplasia: A systematic review and meta-analysis. PLoS One 2019;14:e0219865. [PMID: 31348819 DOI: 10.1371/journal.pone.0219865] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
213 Gomez JM, Patrie JT, Bleibel W, Frye JW, Sauer BG, Shami VM, Stelow EB, Moskaluk CA, Wang AY. Gastric intestinal metaplasia is associated with gastric dysplasia but is inversely correlated with esophageal dysplasia. World J Gastrointest Endosc 2017; 9(2): 61-69 [PMID: 28250898 DOI: 10.4253/wjge.v9.i2.61] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
214 Choi CW, Kim HW, Shin DH, Kang DH, Hong YM, Park JH, Park SB, Cho M, Lee JH. The risk factors for discrepancy after endoscopic submucosal dissection of gastric category 3 lesion (low grade dysplasia). Dig Dis Sci 2014;59:421-7. [PMID: 24366779 DOI: 10.1007/s10620-013-2874-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
215 Mezmale L, Isajevs S, Bogdanova I, Polaka I, Krigere A, Rudzite D, Rudule A, Kikuste I, Parshutin S, Tazhedinov A, Mushinskiy D, Sametayev D, Belikhina T, Igissinov N, Park JY, Herrero R, Leja M. Prevalence of Atrophic Gastritis in Kazakhstan and the Accuracy of Pepsinogen Tests to Detect Gastric Mucosal Atrophy. Asian Pac J Cancer Prev 2019;20:3825-9. [PMID: 31870128 DOI: 10.31557/APJCP.2019.20.12.3825] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
216 Kumar S, Patel GK, Ghoshal UC. Helicobacter pylori-Induced Inflammation: Possible Factors Modulating the Risk of Gastric Cancer. Pathogens 2021;10:1099. [PMID: 34578132 DOI: 10.3390/pathogens10091099] [Reference Citation Analysis]
217 Sakitani K, Hirata Y, Watabe H, Yamada A, Sugimoto T, Yamaji Y, Yoshida H, Maeda S, Omata M, Koike K. Gastric cancer risk according to the distribution of intestinal metaplasia and neutrophil infiltration. J Gastroenterol Hepatol. 2011;26:1570-1575. [PMID: 21575058 DOI: 10.1111/j.1440-1746.2011.06767.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
218 Yang Y, Lin X, Lu X, Luo G, Zeng T, Tang J, Jiang F, Li L, Cui X, Huang W, Hou G, Chen X, Ouyang Q, Tang S, Sun H, Chen L, Gonzalez FJ, Wu M, Cong W, Chen L, Wang H. Interferon-microRNA signalling drives liver precancerous lesion formation and hepatocarcinogenesis. Gut. 2016;65:1186-1201. [PMID: 26860770 DOI: 10.1136/gutjnl-2015-310318] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
219 Lahner E, Conti L, Annibale B, Corleto VD. Current Perspectives in Atrophic Gastritis. Curr Gastroenterol Rep 2020;22:38. [PMID: 32542467 DOI: 10.1007/s11894-020-00775-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
220 Capelle LG, Haringsma J, de Vries AC, Steyerberg EW, Biermann K, van Dekken H, Kuipers EJ. Narrow band imaging for the detection of gastric intestinal metaplasia and dysplasia during surveillance endoscopy. Dig Dis Sci. 2010;55:3442-3448. [PMID: 20393882 DOI: 10.1007/s10620-010-1189-2] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 5.7] [Reference Citation Analysis]
221 Kim HH, Kim JH, Kim GH, Choi M, Jee SR, Song GA. Causes of missed synchronous gastric epithelial neoplasms with endoscopic submucosal dissection: a multicenter study. Scandinavian Journal of Gastroenterology 2013;48:1339-46. [DOI: 10.3109/00365521.2013.838607] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
222 Zeng J, Pan H, Liu Y, Xu H, Zhao Z, Li H, Ren J, Chen L, Hu X, Yan Y. Effects of Weipixiao (胃痞消) on Wnt pathway-associated proteins in gastric mucosal epithelial cells from rats with gastric precancerous lesions. Chin J Integr Med 2016;22:267-75. [DOI: 10.1007/s11655-015-2131-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
223 Annibale B, Esposito G, Lahner E. A current clinical overview of atrophic gastritis. Expert Review of Gastroenterology & Hepatology 2020;14:93-102. [DOI: 10.1080/17474124.2020.1718491] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
224 Chen WC, Warner RR, Ward SC, Harpaz N, Divino CM, Itzkowitz SH, Kim MK. Management and disease outcome of type I gastric neuroendocrine tumors: the Mount Sinai experience. Dig Dis Sci. 2015;60:996-1003. [PMID: 25399327 DOI: 10.1007/s10620-014-3410-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
225 Waldum HL, Sagatun L, Mjønes P. Gastrin and Gastric Cancer. Front Endocrinol (Lausanne) 2017;8:1. [PMID: 28144230 DOI: 10.3389/fendo.2017.00001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
226 Zhang X, Li M, Chen S, Hu J, Guo Q, Liu R, Zheng H, Jin Z, Yuan Y, Xi Y, Hua B. Endoscopic Screening in Asian Countries Is Associated With Reduced Gastric Cancer Mortality: A Meta-analysis and Systematic Review. Gastroenterology. 2018;155:347-354.e349. [PMID: 29723507 DOI: 10.1053/j.gastro.2018.04.026] [Cited by in Crossref: 72] [Cited by in F6Publishing: 73] [Article Influence: 18.0] [Reference Citation Analysis]
227 Park JS, Yeom JS, Seo JH, Lim JY, Park CH, Woo HO, Youn HS, Jun JS, Park JH, Ko GH, Baik SC, Lee WK, Cho MJ, Rhee KH. Immunohistochemical Expressions of MUC2, MUC5AC, and MUC6 in Normal, Helicobacter pylori Infected and Metaplastic Gastric Mucosa of Children and Adolescents. Helicobacter 2015;20:260-8. [PMID: 25704078 DOI: 10.1111/hel.12198] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
228 Capelle LG, den Hoed CM, de Vries AC, Biermann K, Casparie MK, Meijer GA, Kuipers EJ. Premalignant gastric lesions in patients with gastric mucosa-associated lymphoid tissue lymphoma and metachronous gastric adenocarcinoma: a case–control study. European Journal of Gastroenterology & Hepatology 2012;24:42-7. [DOI: 10.1097/meg.0b013e32834d85e6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
229 Kuo H, Chang W, Yeh Y, Tsai Y, Wu C, Cheng H, Yang H, Lu C, Sheu B. Serum Level of Trefoil Factor 2 can Predict the Extent of Gastric Spasmolytic Polypeptide-Expressing Metaplasia in the H. pylori- Infected Gastric Cancer Relatives. Helicobacter 2017;22:e12320. [DOI: 10.1111/hel.12320] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
230 Lage J, Pimentel-Nunes P, Figueiredo PC, Libanio D, Ribeiro I, Jacome M, Afonso L, Dinis-Ribeiro M. Light-NBI to identify high-risk phenotypes for gastric adenocarcinoma: do we still need biopsies? Scand J Gastroenterol 2016;51:501-6. [PMID: 26506982 DOI: 10.3109/00365521.2015.1101779] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
231 Lage J, Uedo N, Dinis-Ribeiro M, Yao K. Surveillance of patients with gastric precancerous conditions. Best Pract Res Clin Gastroenterol. 2016;30:913-922. [PMID: 27938786 DOI: 10.1016/j.bpg.2016.09.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
232 Pittayanon R, Rerknimitr R, Wisedopas N, Ridtitid W, Kongkam P, Treeprasertsuk S, Angsuwatcharakon P, Mahachai V, Kullavanijaya P. Flexible spectral imaging color enhancement plus probe-based confocal laser endomicroscopy for gastric intestinal metaplasia detection. J Gastroenterol Hepatol. 2013;28:1004-1009. [PMID: 23432088 DOI: 10.1111/jgh.12185] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
233 Liu Y, Lin D, Li L, Chen Y, Wen J, Lin Y, He X. Using machine-learning algorithms to identify patients at high risk of upper gastrointestinal lesions for endoscopy. J Gastroenterol Hepatol 2021. [PMID: 33929063 DOI: 10.1111/jgh.15530] [Reference Citation Analysis]
234 Buxbaum JL, Hormozdi D, Dinis-Ribeiro M, Lane C, Dias-Silva D, Sahakian A, Jayaram P, Pimentel-Nunes P, Shue D, Pepper M, Cho D, Laine L. Narrow-band imaging versus white light versus mapping biopsy for gastric intestinal metaplasia: a prospective blinded trial. Gastrointest Endosc. 2017;86:857-865. [PMID: 28366441 DOI: 10.1016/j.gie.2017.03.1528] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
235 Shichijo S, Hirata Y. Characteristics and predictors of gastric cancer after Helicobacter pylori eradication. World J Gastroenterol 2018; 24(20): 2163-2172 [PMID: 29853734 DOI: 10.3748/wjg.v24.i20.2163] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
236 Quach DT, Hiyama T, Gotoda T. Identifying high-risk individuals for gastric cancer surveillance from western and eastern perspectives: Lessons to learn and possibility to develop an integrated approach for daily practice. World J Gastroenterol 2019; 25(27): 3546-3562 [PMID: 31367156 DOI: 10.3748/wjg.v25.i27.3546] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
237 Barros R, Freund JN, David L, Almeida R. Gastric intestinal metaplasia revisited: function and regulation of CDX2. Trends Mol Med. 2012;18:555-563. [PMID: 22871898 DOI: 10.1016/j.molmed.2012.07.006] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
238 Yoshida T, Kato J, Inoue I, Yoshimura N, Deguchi H, Mukoubayashi C, Oka M, Watanabe M, Enomoto S, Niwa T. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer. Int J Cancer. 2014;134:1445-1457. [PMID: 24009139 DOI: 10.1002/ijc.28470] [Cited by in Crossref: 81] [Cited by in F6Publishing: 80] [Article Influence: 9.0] [Reference Citation Analysis]
239 Liou JM, Lee YC, El-Omar EM, Wu MS. Efficacy and Long-Term Safety of H. pylori Eradication for Gastric Cancer Prevention. Cancers (Basel) 2019;11:E593. [PMID: 31035365 DOI: 10.3390/cancers11050593] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
240 Lee JY, Kim N, Lee HS, Oh JC, Kwon YH, Choi YJ, Yoon KC, Hwang JJ, Lee HJ, Lee A, Jeong Y, Jo HJ, Yoon H, Shin CM, Park YS, Lee DH. Correlations among endoscopic, histologic and serologic diagnoses for the assessment of atrophic gastritis. J Cancer Prev 2014;19:47-55. [PMID: 25337572 DOI: 10.15430/jcp.2014.19.1.47] [Cited by in Crossref: 32] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
241 Kim GH, Liang PS, Bang SJ, Hwang JH. Screening and surveillance for gastric cancer in the United States: Is it needed? Gastrointest Endosc. 2016;84:18-28. [PMID: 26940296 DOI: 10.1016/j.gie.2016.02.028] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 12.2] [Reference Citation Analysis]
242 Zheng J, Bao WQ, Sheng WQ, Guo L, Zhang HL, Wu LH, Wu XZ. Serum 3'-sulfo-Lea indication of gastric cancer metastasis. Clin Chim Acta 2009;405:119-26. [PMID: 19394320 DOI: 10.1016/j.cca.2009.04.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
243 Cho SJ, Choi IJ, Kook MC, Nam BH, Kim CG, Lee JY, Ryu KW, Kim YW. Staging of intestinal- and diffuse-type gastric cancers with the OLGA and OLGIM staging systems. Aliment Pharmacol Ther. 2013;38:1292-1302. [PMID: 24134499 DOI: 10.1111/apt.12515] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 5.1] [Reference Citation Analysis]
244 Xu G, Zhang W, Lv Y, Zhang B, Sun Q, Ling T, Zhang X, Zhou Z, Wang L, Huang Q, Zou X. Risk factors for under-diagnosis of gastric intraepithelial neoplasia and early gastric carcinoma in endoscopic forceps biopsy in comparison with endoscopic submucosal dissection in Chinese patients. Surg Endosc 2016;30:2716-22. [PMID: 26423416 DOI: 10.1007/s00464-015-4534-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
245 Spechler SJ, Merchant JL, Wang TC, Chandrasoma P, Fox JG, Genta RM, Goldenring JR, Hayakawa Y, Kuipers EJ, Lund PK, McKeon F, Mills JC, Odze RD, Peek RM Jr, Pham T, Que J, Rustgi AK, Shaheen NJ, Shivdasani RA, Souza RF, Storz P, Todisco A, Wang DH, Wright NA. A Summary of the 2016 James W. Freston Conference of the American Gastroenterological Association: Intestinal Metaplasia in the Esophagus and Stomach: Origins, Differences, Similarities and Significance. Gastroenterology 2017;153:e6-e13. [PMID: 28583825 DOI: 10.1053/j.gastro.2017.05.050] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
246 Liu Y, Jin Z, Qin X, Zheng Q. Urinary metabolomics research for Huangqi Jianzhong Tang against chronic atrophic gastritis rats based on 1 H NMR and UPLC-Q/TOF MS. J Pharm Pharmacol 2020;72:748-60. [PMID: 32128823 DOI: 10.1111/jphp.13242] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
247 Coelho MCF, Ribeiro HG, Gomes CGO, Marinho FP, Barbosa AJA, Coelho LGV. HELICOBACTER PYLORI CHRONIC GASTRITIS ON PATIENTS WITH PREMALIGNANT CONDITIONS: OLGA AND OLGIM EVALUATION AND SERUM BIOMARKERS PERFORMANCE. Arq Gastroenterol 2021;58:39-47. [PMID: 33909795 DOI: 10.1590/S0004-2803.202100000-08] [Reference Citation Analysis]
248 Duan X, Lian H, Li J, Wu B, Wang W, Wu T, Wang C, Dou Y, Zhou Z, Wang B, Xue L, Wang G. Expression of GCRG213p, LINE-1 endonuclease variant, significantly different in gastric complete and incomplete intestinal metaplasia. Diagn Pathol 2019;14:61. [PMID: 31221180 DOI: 10.1186/s13000-019-0838-9] [Reference Citation Analysis]
249 Sáenz JB. Follow the Metaplasia: Characteristics and Oncogenic Implications of Metaplasia's Pattern of Spread Throughout the Stomach. Front Cell Dev Biol 2021;9:741574. [PMID: 34869328 DOI: 10.3389/fcell.2021.741574] [Reference Citation Analysis]
250 Dai YK, Zhang YZ, Li DY, Ye JT, Zeng LF, Wang Q, Hu L. The efficacy of Jianpi Yiqi therapy for chronic atrophic gastritis: A systematic review and meta-analysis. PLoS One 2017;12:e0181906. [PMID: 28738092 DOI: 10.1371/journal.pone.0181906] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
251 Shin GY, Cho HJ, Park JM, Lim CH, Cho YK, Choi MG. Increased incidence of metachronous gastric neoplasm after endoscopic resection in patients with synchronous gastric neoplasm. BMC Gastroenterol 2020;20:206. [PMID: 32605537 DOI: 10.1186/s12876-020-01358-0] [Reference Citation Analysis]
252 Haringsma J, van Heel NC, Kuipers EJ. Are we making progress in diagnosing and preventing gastrointestinal cancers? Therap Adv Gastroenterol 2010;3:213-20. [PMID: 21180603 DOI: 10.1177/1756283X10372984] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
253 Shin SY, Kim JH. Endoscopic Resection of Gastric Cancer Caused by Adenoma. Gut Liver 2018;12:219-20. [PMID: 29724085 DOI: 10.5009/gnl18161] [Reference Citation Analysis]
254 Lahner E, Hassan C, Esposito G, Carabotti M, Zullo A, Dinis-ribeiro M, Annibale B. Cost of detecting gastric neoplasia by surveillance endoscopy in atrophic gastritis in Italy: A low risk country. Digestive and Liver Disease 2017;49:291-6. [DOI: 10.1016/j.dld.2016.12.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
255 Chao Y, Jin J, Wang L, Jin X, Yang L, Zhang B. Transcriptome Analysis of lncRNA-mRNA Interactions in Chronic Atrophic Gastritis. Front Genet 2020;11:612951. [PMID: 33505433 DOI: 10.3389/fgene.2020.612951] [Reference Citation Analysis]
256 Isajevs S, Liepniece-karele I, Janciauskas D, Moisejevs G, Funka K, Kikuste I, Vanags A, Tolmanis I, Leja M. The effect of incisura angularis biopsy sampling on the assessment of gastritis stage. European Journal of Gastroenterology & Hepatology 2014;26:510-3. [DOI: 10.1097/meg.0000000000000082] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
257 Kwon YJ, Kim N, Baek SM, Lee HS, Lee J, Hwang YJ, Yoon H, Shin CM, Park YS, Kim J, Lee DH. The prevalence of histologic atrophy and intestinal metaplasia in the corpus has decreased over 15 years in females in the Korean population. Helicobacter 2019;24:e12579. [DOI: 10.1111/hel.12579] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
258 Krishnan V, Lim DXE, Hoang PM, Srivastava S, Matsuo J, Huang KK, Zhu F, Ho KY, So JBY, Khor C, Tsao S, Teh M, Fock KM, Ang TL, Jeyasekharan AD, Tan P, Yeoh KG, Ito Y. DNA damage signalling as an anti-cancer barrier in gastric intestinal metaplasia. Gut 2020;69:1738-49. [PMID: 31937549 DOI: 10.1136/gutjnl-2019-319002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
259 Zhou W, Zhang H, Wang X, Kang J, Guo W, Zhou L, Liu H, Wang M, Jia R, Du X, Wang W, Zhang B, Li S. Network pharmacology to unveil the mechanism of Moluodan in the treatment of chronic atrophic gastritis. Phytomedicine 2021;95:153837. [PMID: 34883416 DOI: 10.1016/j.phymed.2021.153837] [Reference Citation Analysis]
260 Kato M, Nishida T, Tsutsui S, Komori M, Michida T, Yamamoto K, Kawai N, Kitamura S, Zushi S, Nishihara A. Endoscopic submucosal dissection as a treatment for gastric noninvasive neoplasia: a multicenter study by Osaka University ESD Study Group. J Gastroenterol. 2011;46:325-331. [PMID: 21107615 DOI: 10.1007/s00535-010-0350-1] [Cited by in Crossref: 68] [Cited by in F6Publishing: 72] [Article Influence: 5.7] [Reference Citation Analysis]
261 Watari J, Chen N, Amenta PS, Fukui H, Oshima T, Tomita T, Miwa H, Lim KJ, Das KM. Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development. World J Gastroenterol 2014; 20(18): 5461-5473 [PMID: 24833876 DOI: 10.3748/wjg.v20.i18.5461] [Cited by in CrossRef: 103] [Cited by in F6Publishing: 90] [Article Influence: 12.9] [Reference Citation Analysis]
262 Merola E, Sbrozzi-Vanni A, Panzuto F, D'Ambra G, Di Giulio E, Pilozzi E, Capurso G, Lahner E, Bordi C, Annibale B, Delle Fave G. Type I Gastric Carcinoids: A Prospective Study on Endoscopic Management and Recurrence Rate. Neuroendocrinology. 2012;95:207-213. [PMID: 21811050 DOI: 10.1159/000329043] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 5.9] [Reference Citation Analysis]
263 Chu F, Li Y, Meng X, Li Y, Li T, Zhai M, Zheng H, Xin T, Su Z, Lin J, Zhang P, Ding X. Gut Microbial Dysbiosis and Changes in Fecal Metabolic Phenotype in Precancerous Lesions of Gastric Cancer Induced With N-Methyl-N'-Nitro-N-Nitrosoguanidine, Sodium Salicylate, Ranitidine, and Irregular Diet. Front Physiol 2021;12:733979. [PMID: 34803728 DOI: 10.3389/fphys.2021.733979] [Reference Citation Analysis]
264 Vance RB Jr, Kubiliun N, Dunbar KB. How Do We Manage Gastric Intestinal Metaplasia? Dig Dis Sci. 2016;61:1870-1878. [PMID: 26984230 DOI: 10.1007/s10620-016-4107-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
265 van der Poorten DK, McLeod D, Ahlenstiel G, Read S, Kwok A, Santhakumar C, Bassan M, Culican S, Campbell D, Wong SWJ, Evans L, Jideh B, Kane A, Katelaris CH, Keat K, Ko Y, Lee JA, Limaye S, Lin MW, Murad A, Rafferty M, Suan D, Swaminathan S, Riminton SD, Toong C, Berglund LJ. Gastric Cancer Screening in Common Variable Immunodeficiency. J Clin Immunol. 2018;38:768-777. [PMID: 30219982 DOI: 10.1007/s10875-018-0546-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
266 Islami F, Sheikhattari P, Ren JS, Kamangar F. Gastric atrophy and risk of oesophageal cancer and gastric cardia adenocarcinoma--a systematic review and meta-analysis. Ann Oncol. 2011;22:754-760. [PMID: 20860989 DOI: 10.1093/annonc/mdq411] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
267 Vannella L, Lahner E, Annibale B. Risk for gastric neoplasias in patients with chronic atrophic gastritis: A critical reappraisal. World J Gastroenterol 2012; 18(12): 1279-1285 [PMID: 22493541 DOI: 10.3748/wjg.v18.i12.1279] [Cited by in CrossRef: 80] [Cited by in F6Publishing: 65] [Article Influence: 8.0] [Reference Citation Analysis]
268 Zhang J, Huang K, Zhong G, Huang Y, Li S, Qu S, Zhang J. Acupuncture Decreases NF-κB p65, miR-155, and miR-21 and Increases miR-146a Expression in Chronic Atrophic Gastritis Rats. Evid Based Complement Alternat Med 2016;2016:9404629. [PMID: 27293468 DOI: 10.1155/2016/9404629] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
269 Gisbert JP, Calvet X, Bermejo F, Boixeda D, Bory F, Bujanda L, Castro-Fernández M, Dominguez-Muñoz E, Elizalde JI, Forné M, Gené E, Gomollón F, Lanas Á, Martín de Argila C, McNicholl AG, Mearin F, Molina-Infante J, Montoro M, Pajares JM, Pérez-Aisa A, Pérez-Trallero E, Sánchez-Delgado J. [III Spanish Consensus Conference on Helicobacter pylori infection]. Gastroenterol Hepatol 2013;36:340-74. [PMID: 23601856 DOI: 10.1016/j.gastrohep.2013.01.011] [Cited by in Crossref: 49] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
270 Fuccio L, Eusebi LH, Bazzoli F. Gastric cancer, Helicobacter pylori infection and other risk factors. World J Gastrointest Oncol 2010; 2(9): 342-347 [PMID: 21160805 DOI: 10.4251/wjgo.v2.i9.342] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
271 Han YM, Chung SJ, Choi JM, Lee C, Kim JS. Long-term outcome of group D patients with negative serum anti-Helicobacter pylori antibody and positive serum pepsinogen test in healthy Koreans. J Dig Dis 2018;19:529-39. [PMID: 30117281 DOI: 10.1111/1751-2980.12660] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
272 Marcus EA, Vagin O, Tokhtaeva E, Sachs G, Scott DR. Helicobacter pylori impedes acid-induced tightening of gastric epithelial junctions. Am J Physiol Gastrointest Liver Physiol. 2013;305:G731-G739. [PMID: 23989011 DOI: 10.1152/ajpgi.00209.2013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
273 He XK, Liu D, Sun LM. Diagnostic performance of confocal laser endomicroscopy for optical diagnosis of gastric intestinal metaplasia: a meta-analysis. BMC Gastroenterol 2016;16:109. [PMID: 27596838 DOI: 10.1186/s12876-016-0515-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
274 Bornschein J, Rokkas T, Selgrad M, Malfertheiner P. Helicobacter pylori and Clinical Aspects of Gastric Cancer. Helicobacter 2009;14:41-5. [DOI: 10.1111/j.1523-5378.2009.00695.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
275 Choi JM, Kim SG, Kim J, Han SJ, Park JY, Oh S, Im JP, Kim JS, Kim WH, Jung HC. Clinical implications of pre-existing adenoma in endoscopically resected early gastric cancers. PLoS One 2017;12:e0178419. [PMID: 28542582 DOI: 10.1371/journal.pone.0178419] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
276 Li T, Guo H, Li H, Jiang Y, Zhuang K, Lei C, Wu J, Zhou H, Zhu R, Zhao X, Lu Y, Shi C, Nie Y, Wu K, Yuan Z, Fan DM, Shi Y. MicroRNA-92a-1-5p increases CDX2 by targeting FOXD1 in bile acids-induced gastric intestinal metaplasia. Gut 2019;68:1751-63. [PMID: 30635407 DOI: 10.1136/gutjnl-2017-315318] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
277 Kobayashi Y, Komazawa Y, Nagaoka M, Takahashi Y, Yuki M, Shizuki T, Nabika T. Helicobacter pylori-negative intestinal-type gastric adenoma successfully treated by endoscopic submucosal dissection: a case report. Endosc Int Open. 2016;4:E986-E989. [PMID: 27652306 DOI: 10.1055/s-0042-112583] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
278 Yu Y, Fang C, Peng C, Shen S, Xu G, Sun Q, Li L, Su C, Zou X. Risk factors for gastric intraepithelial neoplasia in Chinese adults: a case-control study.Cancer Manag Res. 2018;10:2605-2613. [PMID: 30147361 DOI: 10.2147/CMAR.S166472] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
279 Yeh JM, Hur C, Kuntz KM, Ezzati M, Goldie SJ. Cost-effectiveness of treatment and endoscopic surveillance of precancerous lesions to prevent gastric cancer. Cancer 2010;116:2941-53. [PMID: 20564399 DOI: 10.1002/cncr.25030] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 3.7] [Reference Citation Analysis]
280 Gao QY, Wang ZH, Cui Y, Sheng JQ, Zhang KH, Shi RH, Xu JM, Chen WC, Zuo XL, Li SD, Chen YX, Song YY, Fang JY. Evaluation and clinical significance of the stomach age model for evaluating aging of the stomach-a multicenter study in China. BMC Clin Pathol 2014;14:29. [PMID: 25057261 DOI: 10.1186/1472-6890-14-29] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
281 González CA, Pardo ML, Liso JM, Alonso P, Bonet C, Garcia RM, Sala N, Capella G, Sanz-Anquela JM. Gastric cancer occurrence in preneoplastic lesions: a long-term follow-up in a high-risk area in Spain. Int J Cancer. 2010;127:2654-2660. [PMID: 20178099 DOI: 10.1002/ijc.25273] [Cited by in Crossref: 48] [Cited by in F6Publishing: 56] [Article Influence: 4.0] [Reference Citation Analysis]
282 Noto JM, Peek RM Jr. Gastric-to-intestinal transdifferentiation and cancer. Proc Natl Acad Sci U S A 2012;109:20173-4. [PMID: 23184987 DOI: 10.1073/pnas.1218345110] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
283 Yashima K, Sasaki S, Koda M, Kawaguchi K, Harada K, Murawaki Y. Premalignant lesions in gastric cancer. Clin J Gastroenterol 2010;3:6-12. [PMID: 26189899 DOI: 10.1007/s12328-009-0130-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
284 Maev IG, Kazyulin AN. New opportunities for the prevention of gastric cancer. Terapevticheskii arkhiv 2017;89:101-9. [DOI: 10.17116/terarkh2017894101-109] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
285 Grad C, Pop A, Gaborean E, Grad S, Dumitrascu D. Value of GastroPanel in the diagnosis of atrophic gastritis. Exp Ther Med 2021;22:1347. [PMID: 34630701 DOI: 10.3892/etm.2021.10782] [Reference Citation Analysis]
286 Zhang L, Liu Y, You P, Feng G. Occurrence of gastric cancer in patients with atrophic gastritis during long-term follow-up. Scand J Gastroenterol. 2018;53:843-848. [PMID: 29911441 DOI: 10.1080/00365521.2018.1477987] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
287 Uedo N, Yao K, Ishihara R. Screening and treating intermediate lesions to prevent gastric cancer. Gastroenterol Clin North Am. 2013;42:317-335. [PMID: 23639643 DOI: 10.1016/j.gtc.2013.01.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
288 Zakko L, Lutzke L, Wang KK. Screening and Preventive Strategies in Esophagogastric Cancer. Surg Oncol Clin N Am 2017;26:163-78. [PMID: 28279462 DOI: 10.1016/j.soc.2016.10.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
289 Meyer HJ. [Clinical aspects of premalignant lesions of the upper gastrointestinal tract]. Pathologe 2011;32 Suppl 2:202-5. [PMID: 21837400 DOI: 10.1007/s00292-011-1471-x] [Reference Citation Analysis]
290 Lee JY, Park HW, Choi JY, Lee JS, Koo JE, Chung EJ, Chang HS, Choe J, Yang DH, Myung SJ, Jung HY, Yang SK, Byeon JS. Helicobacter pylori Infection with Atrophic Gastritis Is an Independent Risk Factor for Advanced Colonic Neoplasm. Gut Liver. 2016;10:902-909. [PMID: 27458180 DOI: 10.5009/gnl15340] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
291 Hong JB, Xia L, Zuo W, Wang AJ, Xu S, Xiong HF, Chen YX, Zhu X, Lu NH. Risk factors for intestinal metaplasia in concomitant gastric and duodenal ulcer disease. Exp Ther Med 2014;7:929-34. [PMID: 24669253 DOI: 10.3892/etm.2014.1507] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
292 De Vries AC, Kuipers EJ. Helicobacter pylori infection and Nonmalignant Diseases: H. pylori and Nonmalignant Diseases. Helicobacter 2010;15:29-33. [DOI: 10.1111/j.1523-5378.2010.00775.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
293 Taha-Mehlitz S, Mongelli F, Sykora M, Scheiwiller A, Diebold J, Metzger J, Gass JM. Routine histopathologic examination of the resected specimen after laparoscopic sleeve gastrectomy - what can be expected? Acta Chir Belg 2020;:1-6. [PMID: 32644013 DOI: 10.1080/00015458.2020.1794335] [Reference Citation Analysis]
294 Leung WK, Ho HJ, Lin JT, Wu MS, Wu CY. Prior gastroscopy and mortality in patients with gastric cancer: a matched retrospective cohort study. Gastrointest Endosc 2018;87:119-127.e3. [PMID: 28648576 DOI: 10.1016/j.gie.2017.06.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
295 Khawar MB, Abbasi MH, Sheikh N. IL-32: A Novel Pluripotent Inflammatory Interleukin, towards Gastric Inflammation, Gastric Cancer, and Chronic Rhino Sinusitis. Mediators Inflamm. 2016;2016:8413768. [PMID: 27143819 DOI: 10.1155/2016/8413768] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 7.0] [Reference Citation Analysis]
296 Ji Y, Liu Y, Hu J, Cheng C, Xing J, Zhu L, Shen H. Exploring the Molecular Mechanism of Astragali Radix-Curcumae Rhizoma against Gastric Intraepithelial Neoplasia by Network Pharmacology and Molecular Docking. Evid Based Complement Alternat Med 2021;2021:8578615. [PMID: 34646329 DOI: 10.1155/2021/8578615] [Reference Citation Analysis]
297 Schneider BG, Mera R, Piazuelo MB, Bravo JC, Zabaleta J, Delgado AG, Bravo LE, Wilson KT, El-Rifai W, Peek RM Jr, Correa P. DNA Methylation Predicts Progression of Human Gastric Lesions. Cancer Epidemiol Biomarkers Prev 2015;24:1607-13. [PMID: 26269563 DOI: 10.1158/1055-9965.EPI-15-0388] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
298 Lahner E, Zagari RM, Zullo A, Di Sabatino A, Meggio A, Cesaro P, Lenti MV, Annibale B, Corazza GR. Chronic atrophic gastritis: Natural history, diagnosis and therapeutic management. A position paper by the Italian Society of Hospital Gastroenterologists and Digestive Endoscopists [AIGO], the Italian Society of Digestive Endoscopy [SIED], the Italian Society of Gastroenterology [SIGE], and the Italian Society of Internal Medicine [SIMI]. Dig Liver Dis. 2019;51:1621-1632. [PMID: 31635944 DOI: 10.1016/j.dld.2019.09.016] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 9.3] [Reference Citation Analysis]
299 Mills JC, Samuelson LC. Past Questions and Current Understanding About Gastric Cancer. Gastroenterology 2018;155:939-44. [PMID: 29964037 DOI: 10.1053/j.gastro.2018.06.044] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
300 Compare D, Rocco A, Nardone G. Screening for and surveillance of gastric cancer. World J Gastroenterol 2014; 20(38): 13681-13691 [PMID: 25320506 DOI: 10.3748/wjg.v20.i38.13681] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
301 Thrift AP, El-Serag HB. Burden of Gastric Cancer. Clin Gastroenterol Hepatol 2020;18:534-42. [PMID: 31362118 DOI: 10.1016/j.cgh.2019.07.045] [Cited by in Crossref: 134] [Cited by in F6Publishing: 131] [Article Influence: 44.7] [Reference Citation Analysis]
302 Zhao H, Yang X, Zhou Y, Zhang W, Wang Y, Wen J, Zhang Z, Shen L. Potential role of aquaporin 3 in gastric intestinal metaplasia. Oncotarget 2015;6:38926-33. [PMID: 26506416 DOI: 10.18632/oncotarget.5370] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
303 Olmez S, Aslan M, Erten R, Sayar S, Bayram I. The Prevalence of Gastric Intestinal Metaplasia and Distribution of Helicobacter pylori Infection, Atrophy, Dysplasia, and Cancer in Its Subtypes. Gastroenterol Res Pract. 2015;2015:434039. [PMID: 26635875 DOI: 10.1155/2015/434039] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
304 Sekikawa A, Fukui H, Maruo T, Tsumura T, Kanesaka T, Okabe Y, Osaki Y. Gastric xanthelasma may be a warning sign for the presence of early gastric cancer. J Gastroenterol Hepatol. 2014;29:951-956. [PMID: 24372908 DOI: 10.1111/jgh.12512] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
305 Pasechnikov V, Chukov S, Fedorov E, Kikuste I, Leja M. Gastric cancer: Prevention, screening and early diagnosis. World J Gastroenterol 2014; 20(38): 13842-13862 [PMID: 25320521 DOI: 10.3748/wjg.v20.i38.13842] [Cited by in CrossRef: 153] [Cited by in F6Publishing: 145] [Article Influence: 19.1] [Reference Citation Analysis]
306 Shimpoh T, Hirata Y, Ihara S, Suzuki N, Kinoshita H, Hayakawa Y, Ota Y, Narita A, Yoshida S, Yamada A, Koike K. Prevalence of pks-positive Escherichia coli in Japanese patients with or without colorectal cancer. Gut Pathog 2017;9:35. [PMID: 28616082 DOI: 10.1186/s13099-017-0185-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
307 Choi SI, Park B, Joo J, Kim YI, Lee JY, Kim CG, Choi IJ, Kook MC, Cho SJ. Three-year interval for endoscopic screening may reduce the mortality in patients with gastric cancer. Surg Endosc 2019;33:861-9. [PMID: 30006847 DOI: 10.1007/s00464-018-6353-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
308 Shichijo S, Hirata Y, Sakitani K, Yamamoto S, Serizawa T, Niikura R, Watabe H, Yoshida S, Yamada A, Yamaji Y, Ushiku T, Fukayama M, Koike K. Distribution of intestinal metaplasia as a predictor of gastric cancer development. J Gastroenterol Hepatol. 2015;30:1260-1264. [PMID: 25777777 DOI: 10.1111/jgh.12946] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 5.5] [Reference Citation Analysis]
309 Moon HS. Improving the Endoscopic Detection Rate in Patients with Early Gastric Cancer. Clin Endosc 2015;48:291-6. [PMID: 26240801 DOI: 10.5946/ce.2015.48.4.291] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
310 Chung GE, Chung SJ, Yang JI, Jin EH, Park MJ, Kim SG, Kim JS. Development of Metachronous Tumors after Endoscopic Resection for Gastric Neoplasm according to the Baseline Tumor Grade at a Health Checkup Center. Korean J Gastroenterol 2017;70:223. [DOI: 10.4166/kjg.2017.70.5.223] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
311 Jeon JW, Kim SJ, Jang JY, Kim SM, Lim CH, Park JM, Hong SJ, Kim CG, Jeon SW, Lee SH, Sung JK, Baik GH. Clinical Outcomes of Endoscopic Resection for Low-Grade Dysplasia and High-Grade Dysplasia on Gastric Pretreatment Biopsy: Korea ESD Study Group. Gut Liver 2021;15:225-31. [PMID: 32773388 DOI: 10.5009/gnl19275] [Reference Citation Analysis]
312 Capelle LG, de Vries AC, Haringsma J, Steyerberg EW, Looman CW, Nagtzaam NM, van Dekken H, ter Borg F, de Vries RA, Kuipers EJ. Serum levels of leptin as marker for patients at high risk of gastric cancer. Helicobacter. 2009;14:596-604. [PMID: 19889078 DOI: 10.1111/j.1523-5378.2009.00728.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
313 Khanderia E, Markar SR, Acharya A, Kim Y, Kim YW, Hanna GB. The Influence of Gastric Cancer Screening on the Stage at Diagnosis and Survival: A Meta-Analysis of Comparative Studies in the Far East. J Clin Gastroenterol. 2016;50:190-197. [PMID: 26844858 DOI: 10.1097/mcg.0000000000000466] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
314 Malfertheiner P, Megraud F, O'Morain CA, Gisbert JP, Kuipers EJ, Axon AT, Bazzoli F, Gasbarrini A, Atherton J, Graham DY, Hunt R, Moayyedi P, Rokkas T, Rugge M, Selgrad M, Suerbaum S, Sugano K, El-Omar EM; European Helicobacter and Microbiota Study Group and Consensus panel. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut. 2017;66:6-30. [PMID: 27707777 DOI: 10.1136/gutjnl-2016-312288] [Cited by in Crossref: 1166] [Cited by in F6Publishing: 992] [Article Influence: 194.3] [Reference Citation Analysis]
315 Wen KW, Rabinovitch PS, Huang D, Mattis AN, Lauwers GY, Choi W. Use of DNA flow cytometry in the diagnosis, risk stratification, and management of gastric epithelial dysplasia. Mod Pathol 2018;31:1578-87. [DOI: 10.1038/s41379-018-0062-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
316 Siregar GA, Parwati I, Achmad TH, Syukriani YF. Association between VEGF-634G>C Gene Polymorphism with Gastric Premalignant Lesions and Serum VEGF Levels in Helicobacter pylori Gastritis Patients. Open Access Maced J Med Sci 2018;6:1328-34. [PMID: 30159051 DOI: 10.3889/oamjms.2018.266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
317 Shin WG, Kim HU, Song HJ, Hong SJ, Shim KN, Sung IK, Kim JG. Surveillance strategy of atrophic gastritis and intestinal metaplasia in a country with a high prevalence of gastric cancer. Dig Dis Sci. 2012;57:746-752. [PMID: 21984437 DOI: 10.1007/s10620-011-1919-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
318 Leja M, Cine E, Rudzite D, Vilkoite I, Huttunen T, Daugule I, Rumba-Rozenfelde I, Pimanov S, Liepniece-Karele I, Pahomova J, Purmalis K, Eglitis J, Pirags V, Dzerve V, Erglis A. Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia. Eur J Gastroenterol Hepatol 2012;24:1410-7. [PMID: 23114744 DOI: 10.1097/MEG.0b013e3283583ca5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
319 Businello G, Angerilli V, Parente P, Realdon S, Savarino E, Farinati F, Grillo F, Vanoli A, Galuppini F, Paccagnella S, Pennelli G, Mastracci L, Saragoni L, Fassan M. Molecular Landscapes of Gastric Pre-Neoplastic and Pre-Invasive Lesions. Int J Mol Sci 2021;22:9950. [PMID: 34576114 DOI: 10.3390/ijms22189950] [Reference Citation Analysis]
320 Brown JW, Das KK, Kalas V, Das KM, Mills JC. mAb Das-1 recognizes 3'-Sulfated Lewis A/C, which is aberrantly expressed during metaplastic and oncogenic transformation of several gastrointestinal Epithelia. PLoS One 2021;16:e0261082. [PMID: 34910746 DOI: 10.1371/journal.pone.0261082] [Reference Citation Analysis]
321 Kuipers EJ. Editorial: proton pump inhibitors, Helicobacter pylori and gastric cancer--the need for long-term follow-up. Aliment Pharmacol Ther 2016;43:647-8. [PMID: 26843338 DOI: 10.1111/apt.13504] [Reference Citation Analysis]
322 . UEG Week 2016 Poster Presentations. United European Gastroenterology Journal 2016;4:A157-720. [DOI: 10.1177/2050640616663689] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
323 Kuipers EJ. When Is Endoscopic Follow-up Appropriate After Helicobacter pylori Eradication Therapy? Gastroenterology Clinics of North America 2015;44:597-608. [DOI: 10.1016/j.gtc.2015.05.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
324 Yep-Gamarra V, Díaz-Vélez C, Araujo I, Ginès À, Fernández-Esparrach G. [Usefulness of systematic chromoendoscopy with a double dye staining technique for the detection of dysplasia in patients with premalignant gastric lesions]. Gastroenterol Hepatol 2016;39:49-54. [PMID: 26548735 DOI: 10.1016/j.gastrohep.2015.08.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
325 Corvalán AH, Maturana MJ. [Infections and epigenetic changes in cancer]. Rev Chil Pediatr 2016;87:245-9. [PMID: 27474231 DOI: 10.1016/j.rchipe.2016.06.008] [Reference Citation Analysis]
326 Yang L, Jin P, Wang X, Zhang T, He YQ, Zhao XJ, Li N, Yang GZ, Sheng JQ. Risk factors associated with histological upgrade of gastric low-grade dysplasia on pretreatment biopsy. J Dig Dis 2018;19:596-604. [PMID: 30187683 DOI: 10.1111/1751-2980.12669] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
327 Bang CS, Lee JJ, Baik GH. Diagnostic performance of serum pepsinogen assay for the prediction of atrophic gastritis and gastric neoplasms: Protocol for a systematic review and meta-analysis. Medicine (Baltimore) 2019;98:e14240. [PMID: 30681610 DOI: 10.1097/MD.0000000000014240] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
328 Jun JK, Choi KS, Lee HY, Suh M, Park B, Song SH, Jung KW, Lee CW, Choi IJ, Park EC, Lee D. Effectiveness of the Korean National Cancer Screening Program in Reducing Gastric Cancer Mortality. Gastroenterology. 2017;152:1319-1328.e7. [PMID: 28147224 DOI: 10.1053/j.gastro.2017.01.029] [Cited by in Crossref: 145] [Cited by in F6Publishing: 127] [Article Influence: 29.0] [Reference Citation Analysis]
329 Tu H, Sun L, Dong X, Gong Y, Xu Q, Jing J, Long Q, Flanders WD, Bostick RM, Yuan Y. Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: A longitudinal study. Int J Cancer. 2014; Jun 4. [Epub ahead of print]. [PMID: 24895149 DOI: 10.1002/ijc.29005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
330 Chen QF, Zhou XD, Fang DH, Zhang EG, Lin CJ, Feng XZ, Wang N, Wu JS, Wang D, Lin WH. Helicobacter pylori infection with atrophic gastritis: An independent risk factor for colorectal adenomas. World J Gastroenterol 2020; 26(37): 5682-5692 [PMID: 33088161 DOI: 10.3748/wjg.v26.i37.5682] [Cited by in CrossRef: 1] [Article Influence: 0.5] [Reference Citation Analysis]
331 Leeuwenburgh I, Scholten P, Alderliesten J, Tilanus HW, Looman CW, Steijerberg EW, Kuipers EJ. Long-term esophageal cancer risk in patients with primary achalasia: a prospective study. Am J Gastroenterol. 2010;105:2144-2149. [PMID: 20588263 DOI: 10.1038/ajg.2010.263] [Cited by in Crossref: 106] [Cited by in F6Publishing: 72] [Article Influence: 8.8] [Reference Citation Analysis]
332 Lee SY, Byeon S, Ko J, Hyung S, Lee IK, Jeon NL, Hong JY, Kim ST, Park SH, Lee J. Reducing tumor invasiveness by ramucirumab and TGF-β receptor kinase inhibitor in a diffuse-type gastric cancer patient-derived cell model. Cancer Med 2021;10:7253-62. [PMID: 34542244 DOI: 10.1002/cam4.4259] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
333 Aumpan N, Vilaichone RK, Pornthisarn B, Chonprasertsuk S, Siramolpiwat S, Bhanthumkomol P, Nunanan P, Issariyakulkarn N, Ratana-Amornpin S, Miftahussurur M, Mahachai V, Yamaoka Y. Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial). PLoS One 2021;16:e0255601. [PMID: 34379655 DOI: 10.1371/journal.pone.0255601] [Reference Citation Analysis]
334 Hyun YS, Han DS, Bae JH, Park HS, Eun CS. Interobserver variability and accuracy of high-definition endoscopic diagnosis for gastric intestinal metaplasia among experienced and inexperienced endoscopists. J Korean Med Sci 2013;28:744-9. [PMID: 23678267 DOI: 10.3346/jkms.2013.28.5.744] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
335 Zhou JC, Guo JF, Teng RY, Wang QC, Wang J, Wei Q, Li ZD, Shen JG, Wang LB. New utility of an old marker: serum low-density lipoprotein predicts histopathological response of neoadjuvant chemotherapy in locally advanced gastric cancer. Onco Targets Ther 2016;9:5041-7. [PMID: 27574445 DOI: 10.2147/OTT.S97061] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
336 Cubiella J, Pérez Aisa Á, Cuatrecasas M, Díez Redondo P, Fernández Esparrach G, Marín-Gabriel JC, Moreira L, Núñez H, Pardo López ML, Rodríguez de Santiago E, Rosón P, Sanz Anquela JM, Calvet X; en representación de la Asociación Española de Gastroenterología, la Sociedad Española de Endoscopia Digestiva y la Sociedad Española de Anatomía Patológica. Gastric cancer screening in low incidence populations: Position statement of AEG, SEED and SEAP. Gastroenterol Hepatol 2021;44:67-86. [PMID: 33252332 DOI: 10.1016/j.gastrohep.2020.08.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
337 Pimentel-Nunes P, Libânio D, Dinis-Ribeiro M. Evaluation and Management of Gastric Superficial Neoplastic Lesions. GE Port J Gastroenterol 2017;24:8-21. [PMID: 28848776 DOI: 10.1159/000450870] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
338 Piazuelo MB, Bravo LE, Mera RM, Camargo MC, Bravo JC, Delgado AG, Washington MK, Rosero A, Garcia LS, Realpe JL, Cifuentes SP, Morgan DR, Peek RM Jr, Correa P, Wilson KT. The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions. Gastroenterology 2021;160:1106-1117.e3. [PMID: 33220252 DOI: 10.1053/j.gastro.2020.11.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
339 Zhou Q, Li H, Jing J, Yuan Y, Sun L. Evaluation of C5orf66-AS1 as a Potential Biomarker for Predicting Early Gastric Cancer and Its Role in Gastric Carcinogenesis. Onco Targets Ther 2020;13:2795-805. [PMID: 32308414 DOI: 10.2147/OTT.S239965] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
340 Chatelain D, Attencourt C, Flejou J. Les classifications des gastrites: mise au point. Revue Francophone des Laboratoires 2014;2014:31-40. [DOI: 10.1016/s1773-035x(14)72313-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
341 de Vries AC, Haringsma J, de Vries RA, ter Borg F, Nagtzaam NM, Steyerberg EW, van Dekken H, Kuipers EJ. The use of clinical, histologic, and serologic parameters to predict the intragastric extent of intestinal metaplasia: a recommendation for routine practice. Gastrointest Endosc 2009;70:18-25. [PMID: 19249770 DOI: 10.1016/j.gie.2008.08.041] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
342 Liu KSH, Wong IOL, Leung WK. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance. World J Gastroenterol 2016; 22(3): 1311-1320 [PMID: 26811668 DOI: 10.3748/wjg.v22.i3.1311] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
343 Sandoval-Bórquez A, Saavedra K, Carrasco-Avino G, Garcia-Bloj B, Fry J, Wichmann I, Corvalán AH. Noncoding Genomics in Gastric Cancer and the Gastric Precancerous Cascade: Pathogenesis and Biomarkers. Dis Markers 2015;2015:503762. [PMID: 26379360 DOI: 10.1155/2015/503762] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
344 Ngamruengphong S, Abe S, Oda I. Endoscopic Management of Early Gastric Adenocarcinoma and Preinvasive Gastric Lesions. Surg Clin North Am 2017;97:371-85. [PMID: 28325192 DOI: 10.1016/j.suc.2016.11.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
345 Nishida T, Tsujii M, Kato M, Hayashi Y, Akasaka T, Iijima H, Takehara T. Endoscopic surveillance strategy after endoscopic resection for early gastric cancer. World J Gastrointest Pathophysiol 2014; 5(2): 100-106 [PMID: 24891981 DOI: 10.4291/wjgp.v5.i2.100] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
346 Nieminen AA, Kontto J, Puolakkainen P, Virtamo J, Kokkola A. Comparison of operative link for gastritis assessment, operative link on gastric intestinal metaplasia assessment, and TAIM stagings among men with atrophic gastritis. World J Gastroenterol 2020; 26(24): 3447-3457 [PMID: 32655268 DOI: 10.3748/wjg.v26.i24.3447] [Reference Citation Analysis]
347 Liu Y, Cai Y, Chen S, Gou Y, Wang Q, Zhang M, Wang Y, Hong H, Zhang K. Analysis of Risk Factors of Gastric Low-Grade Intraepithelial Neoplasia in Asymptomatic Subjects Undergoing Physical Examination. Gastroenterol Res Pract 2020;2020:7907195. [PMID: 32256566 DOI: 10.1155/2020/7907195] [Reference Citation Analysis]
348 Akbari M, Kardeh B, Tabrizi R, Ahmadizar F, Lankarani KB. Incidence Rate of Gastric Cancer Adenocarcinoma in Patients With Gastric Dysplasia: A Systematic Review and Meta-Analysis. J Clin Gastroenterol 2019;53:703-10. [PMID: 31415022 DOI: 10.1097/MCG.0000000000001257] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
349 Jin S, Jeon SW, Kwon Y, Nam SY, Yeo SJ, Kwon SH, Lee SJ. Optimal Endoscopic Screening Interval for Early Detection of Gastric Cancer: a Single-Center Study. J Korean Med Sci 2018;33:e166. [PMID: 29853821 DOI: 10.3346/jkms.2018.33.e166] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
350 Kato M, Hayashi Y, Nishida T, Oshita M, Nakanishi F, Yamaguchi S, Kitamura S, Nishihara A, Akasaka T, Ogiyama H, Nakahara M, Yamada T, Kishida O, Yamamoto M, Shimayoshi A, Tsujii Y, Kato M, Shinzaki S, Iijima H, Takehara T. Helicobacter pylori eradication prevents secondary gastric cancer in patients with mild‐to‐moderate atrophic gastritis. Journal of Gastroenterology and Hepatology 2021;36:2083-90. [DOI: 10.1111/jgh.15396] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
351 Kuipers EJ. Gastric Cancer: Synopsis and Epidemiology of Gastric Cancer. In: Kim N, editor. Helicobacter pylori. Singapore: Springer; 2016. pp. 241-9. [DOI: 10.1007/978-981-287-706-2_21] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
352 Diaz LI, Mony S, Klapman J. Narrative review of the role of gastroenterologist in the diagnosis, treatment and palliation in gastric and gastroesophageal cancer. Ann Transl Med 2020;8:1106. [PMID: 33145325 DOI: 10.21037/atm-20-4143] [Reference Citation Analysis]
353 Wang X, Lu B, Meng L, Fan Y, Zhang S, Li M. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China. Scand J Gastroenterol. 2017;52:822-827. [PMID: 28436254 DOI: 10.1080/00365521.2017.1315739] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
354 Sadjadi A, Derakhshan MH, Yazdanbod A, Boreiri M, Parsaeian M, Babaei M, Alimohammadian M, Samadi F, Etemadi A, Pourfarzi F, Ahmadi E, Delavari A, Islami F, Farzadfar F, Sotoudeh M, Nikmanesh A, Alizadeh BZ, de Bock GH, Malekzadeh R. Neglected role of hookah and opium in gastric carcinogenesis: a cohort study on risk factors and attributable fractions. Int J Cancer 2014;134:181-8. [PMID: 23797606 DOI: 10.1002/ijc.28344] [Cited by in Crossref: 40] [Cited by in F6Publishing: 47] [Article Influence: 4.4] [Reference Citation Analysis]
355 O’connor A, Bowden A, Farrell E, Weininger J, Crowther S, Mcnamara D, Ridgway P, O’morain C. Risk of Progression of Gastric Intestinal Metaplasia Is Significantly Greater When Detected in Both Antrum and Body. Dig Dis Sci 2021;66:3470-5. [DOI: 10.1007/s10620-020-06659-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
356 Amal H, Leja M, Funka K, Skapars R, Sivins A, Ancans G, Liepniece-Karele I, Kikuste I, Lasina I, Haick H. Detection of precancerous gastric lesions and gastric cancer through exhaled breath. Gut. 2015;Epub ahead of print. [PMID: 25869737 DOI: 10.1136/gutjnl-2014-308536] [Cited by in Crossref: 85] [Cited by in F6Publishing: 81] [Article Influence: 12.1] [Reference Citation Analysis]
357 Companioni O, Bonet C, García N, Ramírez-lázaro MJ, Lario S, Mendoza J, Adrados MM, Poves E, Espinosa L, Pozo-kreilinger JJ, Ortega L, Bujanda L, Cosme A, Ferrández A, Muñoz G, Cuatrecasas M, Elizalde I, Andreu V, Paules MJ, Madrigal B, Barrio J, Berdasco M, Calvet X, Sanz-anquela JM, Gisbert JP, González CA, Sala N; on behalf of the Study Group. Genetic variation analysis in a follow-up study of gastric cancer precursor lesions confirms the association of MUC2 variants with the evolution of the lesions and identifies a significant association with NFKB1 and CD14: Genetic variation and gastric cancer precursor lesions. Int J Cancer 2018;143:2777-86. [DOI: 10.1002/ijc.31839] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
358 Gu J, Xie S, Wang S, Xue L, Zhou J, Li M, Fan Z, Chen R, Middleton DRS, Hao C, Wang J, Li B, Li X, Wei W. Surveillance of premalignant gastric cardia lesions: A population-based prospective cohort study in China. Int J Cancer 2021;149:1639-48. [PMID: 34181269 DOI: 10.1002/ijc.33720] [Reference Citation Analysis]
359 Oetjens MT, Bush WS, Denny JC, Birdwell K, Kodaman N, Verma A, Dilks HH, Pendergrass SA, Ritchie MD, Crawford DC. Evidence for extensive pleiotropy among pharmacogenes. Pharmacogenomics 2016;17:853-66. [PMID: 27249515 DOI: 10.2217/pgs-2015-0007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
360 Sakitani K, Hirata Y, Hayakawa Y, Serizawa T, Nakata W, Takahashi R, Kinoshita H, Sakamoto K, Nakagawa H, Akanuma M. Role of interleukin-32 in Helicobacter pylori-induced gastric inflammation. Infect Immun. 2012;80:3795-3803. [PMID: 22890997 DOI: 10.1128/iai.00637-12] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
361 Yan T, Wong PK, Qin YY. Deep learning for diagnosis of precancerous lesions in upper gastrointestinal endoscopy: A review. World J Gastroenterol 2021; 27(20): 2531-2544 [PMID: 34092974 DOI: 10.3748/wjg.v27.i20.2531] [Reference Citation Analysis]
362 Gao Y, Xi H, Chen L. Does Endoscopic Screening Really Not Alter the Incidence of Gastric Cancer? Gastroenterology 2021;161:374-5. [PMID: 33745947 DOI: 10.1053/j.gastro.2018.07.060] [Reference Citation Analysis]
363 Hassan C, Zullo A, Di Giulio E, Annibale B, Lahner E, De Francesco V, Ierardi E. Cost-effectiveness of endoscopic surveillance for gastric intestinal metaplasia. Helicobacter. 2010;15:221-226. [PMID: 20557364 DOI: 10.1111/j.1523-5378.2010.00752.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
364 Kohoutova D, Banks M, Bures J. Advances in the Aetiology & Endoscopic Detection and Management of Early Gastric Cancer. Cancers (Basel) 2021;13:6242. [PMID: 34944861 DOI: 10.3390/cancers13246242] [Reference Citation Analysis]
365 Barros R, da Costa LT, Pinto-de-Sousa J, Duluc I, Freund JN, David L, Almeida R. CDX2 autoregulation in human intestinal metaplasia of the stomach: impact on the stability of the phenotype. Gut. 2011;60:290-298. [PMID: 21148572 DOI: 10.1136/gut.2010.222323] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
366 Fan YF, Wei MX. Precancerous lesions of gastric cancer: Research progress and preventive strategies. Shijie Huaren Xiaohua Zazhi 2012; 20(20): 1807-1812 [DOI: 10.11569/wcjd.v20.i20.1807] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
367 Zhang XY, Zhang PY. Gastric cancer: somatic genetics as a guide to therapy. J Med Genet. 2016; Sep 8. [Epub ahead of print]. [PMID: 27609016 DOI: 10.1136/jmedgenet-2016-104171] [Cited by in Crossref: 29] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
368 Hassan C, Zullo A, Cristofari F, Lorenzetti R. Upper endoscopy in Europe: are we missing gastric cancer? J Clin Gastroenterol. 2010;44:73. [PMID: 19661815 DOI: 10.1097/mcg.0b013e3181a74802] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
369 Shin N, Jo H, Kim W, Park W, Lee J, Shin DH, Choi KU, Kim J, Lee C, Sol MY, Jeon TY, Kim DW, Huh G, Kim GH, Lauwers GY, Park DY. Gastric Pit Dysplasia in Adjacent Gastric Mucosa in 414 Gastric Cancers: Prevalence and Characteristics. American Journal of Surgical Pathology 2011;35:1021-9. [DOI: 10.1097/pas.0b013e31821ec495] [Cited by in Crossref: 21] [Cited by in F6Publishing: 3] [Article Influence: 1.9] [Reference Citation Analysis]
370 Chapelle N, Petryszyn P, Blin J, Leroy M, Le Berre-Scoul C, Jirka I, Neunlist M, Moussata D, Lamarque D, Olivier R, Tougeron D, Mosnier JF, Matysiak-Budnik T. A panel of stomach-specific biomarkers (GastroPanel®) for the diagnosis of atrophic gastritis: A prospective, multicenter study in a low gastric cancer incidence area. Helicobacter 2020;25:e12727. [PMID: 32700438 DOI: 10.1111/hel.12727] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
371 Luo C, Sun Z, Li Z, Zheng L, Zhu X. Notoginsenoside R1 (NGR1) Attenuates Chronic Atrophic Gastritis in Rats. Med Sci Monit 2019;25:1177-86. [PMID: 30757999 DOI: 10.12659/MSM.911512] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
372 Lee J, Chung SJ, Choi JM, Han YM, Kim JS. Clinicopathologic Characteristics and Long-Term Outcome of Gastric Cancer Patients with Family History: Seven-Year Follow-Up Study for Korean Health Check-Up Subjects. Gastroenterol Res Pract 2020;2020:4028136. [PMID: 33144855 DOI: 10.1155/2020/4028136] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
373 Malfertheiner P, Bornschein J, Selgrad M. Role of Helicobacter pylori infection in gastric cancer pathogenesis: a chance for prevention. J Dig Dis. 2010;11:2-11. [PMID: 20132425 DOI: 10.1111/j.1751-2980.2009.00408.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
374 Rollan A, Arab JP, Camargo MC, Candia R, Harris P, Ferreccio C, Rabkin CS, Gana JC, Cortés P, Herrero R, Durán L, García A, Toledo C, Espino A, Lustig N, Sarfatis A, Figueroa C, Torres J, Riquelme A. Management of Helicobacter pylori infection in Latin America: A Delphi technique-based consensus. World J Gastroenterol 2014; 20(31): 10969-10983 [PMID: 25152601 DOI: 10.3748/wjg.v20.i31.10969] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
375 Shichijo S, Hirata Y, Niikura R, Hayakawa Y, Yamada A, Ushiku T, Fukayama M, Koike K. Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication. Gastrointest Endosc. 2016;84:618-624. [PMID: 26995689 DOI: 10.1016/j.gie.2016.03.791] [Cited by in Crossref: 94] [Cited by in F6Publishing: 82] [Article Influence: 15.7] [Reference Citation Analysis]
376 Song H, Held M, Sandin S, Rautelin H, Eliasson M, Söderberg S, Hallmans G, Engstrand L, Nyrén O, Ye W. Increase in the Prevalence of Atrophic Gastritis Among Adults Age 35 to 44 Years Old in Northern Sweden Between 1990 and 2009. Clin Gastroenterol Hepatol 2015;13:1592-600.e1. [PMID: 25857683 DOI: 10.1016/j.cgh.2015.04.001] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
377 Panarese A, Galatola G, Armentano R, Pimentel-Nunes P, Ierardi E, Caruso ML, Pesce F, Lenti MV, Palmitessa V, Coletta S, Shahini E. Helicobacter pylori-induced inflammation masks the underlying presence of low-grade dysplasia on gastric lesions. World J Gastroenterol 2020; 26(26): 3834-3850 [PMID: 32774061 DOI: 10.3748/wjg.v26.i26.3834] [Reference Citation Analysis]
378 Matkovic E, Schwalbe M, Matkowskyj KA. Pathologic Features of Esophageal and Gastric Malignancies. Cancer Treat Res 2016;168:17-43. [PMID: 29206017 DOI: 10.1007/978-3-319-34244-3_2] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
379 Sekikawa A, Fukui H, Sada R, Fukuhara M, Marui S, Tanke G, Endo M, Ohara Y, Matsuda F, Nakajima J, Henmi S, Saito S, Tsumura T, Maruo T, Kimura T, Osaki Y. Gastric atrophy and xanthelasma are markers for predicting the development of early gastric cancer. J Gastroenterol. 2016;51:35-42. [PMID: 25904098 DOI: 10.1007/s00535-015-1081-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]